CA2471661A1 - Molecular hepatotoxicology modeling - Google Patents

Info

Publication number

CA2471661A1

CA2471661A1 CA002471661A CA2471661A CA2471661A1 CA 2471661 A1 CA2471661 A1 CA 2471661A1 CA 002471661 A CA002471661 A CA 002471661A CA 2471661 A CA2471661 A CA 2471661A CA 2471661 A1 CA2471661 A1 CA 2471661A1

Authority

CA

Canada

Prior art keywords

genes

protein

expression

mrna

ests

Prior art date

2002-01-31

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 108090000623 proteins and genes Proteins 0.000 claims abstract description 446
• 239000000523 sample Substances 0.000 claims abstract description 161
• 230000014509 gene expression Effects 0.000 claims abstract description 160
• 210000004185 liver Anatomy 0.000 claims abstract description 69
• 230000001988 toxicity Effects 0.000 claims abstract description 41
• 231100000419 toxicity Toxicity 0.000 claims abstract description 41
• 239000003053 toxin Substances 0.000 claims abstract description 41
• 231100000765 toxin Toxicity 0.000 claims abstract description 41
• 210000005229 liver cell Anatomy 0.000 claims abstract description 8
• 210000005228 liver tissue Anatomy 0.000 claims abstract description 8
• 238000002493 microarray Methods 0.000 claims abstract description 6
• 102000004169 proteins and genes Human genes 0.000 claims description 164
• 238000000034 method Methods 0.000 claims description 111
• 210000004027 cell Anatomy 0.000 claims description 108
• 150000001875 compounds Chemical class 0.000 claims description 73
• 239000003795 chemical substances by application Substances 0.000 claims description 70
• 210000001519 tissue Anatomy 0.000 claims description 65
• 230000000694 effects Effects 0.000 claims description 57
• 238000012360 testing method Methods 0.000 claims description 46
• 238000009396 hybridization Methods 0.000 claims description 38
• 231100000304 hepatotoxicity Toxicity 0.000 claims description 36
• 230000002588 toxic effect Effects 0.000 claims description 30
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 28
• UMFJAHHVKNCGLG-UHFFFAOYSA-N n-Nitrosodimethylamine Chemical compound CN(C)N=O UMFJAHHVKNCGLG-UHFFFAOYSA-N 0.000 claims description 28
• 231100000331 toxic Toxicity 0.000 claims description 28
• 206010019851 Hepatotoxicity Diseases 0.000 claims description 27
• OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 26
• 230000007686 hepatotoxicity Effects 0.000 claims description 26
• 239000007787 solid Substances 0.000 claims description 21
• 108091034117 Oligonucleotide Proteins 0.000 claims description 20
• 231100000784 hepatotoxin Toxicity 0.000 claims description 19
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 18
• IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims description 16
• 238000003556 assay Methods 0.000 claims description 16
• CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims description 16
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 14
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 13
• MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 13
• KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 claims description 13
• 229960001214 clofibrate Drugs 0.000 claims description 13
• DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims description 13
• 229960001259 diclofenac Drugs 0.000 claims description 13
• AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 claims description 13
• 229960001685 tacrine Drugs 0.000 claims description 13
• YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 claims description 13
• CZIHNRWJTSTCEX-UHFFFAOYSA-N 2 Acetylaminofluorene Chemical compound C1=CC=C2C3=CC=C(NC(=O)C)C=C3CC2=C1 CZIHNRWJTSTCEX-UHFFFAOYSA-N 0.000 claims description 12
• 229940102566 valproate Drugs 0.000 claims description 12
• 208000005623 Carcinogenesis Diseases 0.000 claims description 11
• 229960004150 aciclovir Drugs 0.000 claims description 11
• 230000036952 cancer formation Effects 0.000 claims description 11
• 231100000504 carcinogenesis Toxicity 0.000 claims description 11
• HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 claims description 11
• 238000001727 in vivo Methods 0.000 claims description 11
• 230000007170 pathology Effects 0.000 claims description 11
• YUKQRDCYNOVPGJ-UHFFFAOYSA-N thioacetamide Chemical compound CC(N)=S YUKQRDCYNOVPGJ-UHFFFAOYSA-N 0.000 claims description 11
• DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 11
• 229960000616 diflunisal Drugs 0.000 claims description 10
• 208000006454 hepatitis Diseases 0.000 claims description 10
• 238000000338 in vitro Methods 0.000 claims description 10
• SZRPDCCEHVWOJX-UHFFFAOYSA-N pirinixic acid Chemical compound CC1=CC=CC(NC=2N=C(SCC(O)=O)N=C(Cl)C=2)=C1C SZRPDCCEHVWOJX-UHFFFAOYSA-N 0.000 claims description 10
• HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 claims description 9
• 231100000283 hepatitis Toxicity 0.000 claims description 9
• LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 claims description 8
• JBDOSUUXMYMWQH-UHFFFAOYSA-N 1-naphthyl isothiocyanate Chemical compound C1=CC=C2C(N=C=S)=CC=CC2=C1 JBDOSUUXMYMWQH-UHFFFAOYSA-N 0.000 claims description 8
• 229960000997 bicalutamide Drugs 0.000 claims description 8
• 229960001338 colchicine Drugs 0.000 claims description 8
• 229960000905 indomethacin Drugs 0.000 claims description 8
• 239000012528 membrane Substances 0.000 claims description 8
• 230000008791 toxic response Effects 0.000 claims description 8
• UERHIZBSLAGDLU-UHFFFAOYSA-N 3-(2,3,4,5,6,7,8,8a-octahydro-1h-pyrrolo[1,2-a]pyrazine-2,5-diium-2-yl)-1-(2-chlorophenothiazin-10-yl)propan-1-one;dichloride Chemical compound Cl.Cl.C1CN2CCCC2CN1CCC(=O)N1C2=CC=CC=C2SC2=CC=C(Cl)C=C21 UERHIZBSLAGDLU-UHFFFAOYSA-N 0.000 claims description 7
• DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 claims description 7
• 229960002695 phenobarbital Drugs 0.000 claims description 7
• 230000035755 proliferation Effects 0.000 claims description 7
• 229940041603 vitamin k 3 Drugs 0.000 claims description 7
• QDPMHXUWMPNTEQ-UHFFFAOYSA-N 2-amino-7-(thiophen-3-ylmethyl)-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one Chemical compound C1=2NC(N)=NC(=O)C=2NC=C1CC=1C=CSC=1 QDPMHXUWMPNTEQ-UHFFFAOYSA-N 0.000 claims description 6
• 206010008635 Cholestasis Diseases 0.000 claims description 6
• HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 claims description 6
• 206010019842 Hepatomegaly Diseases 0.000 claims description 6
• 229960003627 gemfibrozil Drugs 0.000 claims description 6
• 235000012711 vitamin K3 Nutrition 0.000 claims description 6
• 239000011652 vitamin K3 Substances 0.000 claims description 6
• MWLSOWXNZPKENC-SSDOTTSWSA-N zileuton Chemical compound C1=CC=C2SC([C@H](N(O)C(N)=O)C)=CC2=C1 MWLSOWXNZPKENC-SSDOTTSWSA-N 0.000 claims description 6
• 229960005332 zileuton Drugs 0.000 claims description 6
• BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims description 5
• 230000003321 amplification Effects 0.000 claims description 5
• 230000004640 cellular pathway Effects 0.000 claims description 5
• 231100000359 cholestasis Toxicity 0.000 claims description 5
• 230000007870 cholestasis Effects 0.000 claims description 5
• 206010019692 hepatic necrosis Diseases 0.000 claims description 5
• 230000004054 inflammatory process Effects 0.000 claims description 5
• 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
• 210000002824 peroxisome Anatomy 0.000 claims description 5
• 239000011521 glass Substances 0.000 claims description 4
• 231100000149 liver necrosis Toxicity 0.000 claims description 4
• 208000004930 Fatty Liver Diseases 0.000 claims description 3
• 206010061218 Inflammation Diseases 0.000 claims description 3
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
• MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims description 3
• 208000019423 liver disease Diseases 0.000 claims description 3
• 239000010703 silicon Substances 0.000 claims description 3
• 229910052710 silicon Inorganic materials 0.000 claims description 3
• 238000000636 Northern blotting Methods 0.000 claims description 2
• 101710163270 Nuclease Proteins 0.000 claims description 2
• 238000003753 real-time PCR Methods 0.000 claims description 2
• 108700012359 toxins Proteins 0.000 abstract description 33
• 238000007878 drug screening assay Methods 0.000 abstract 1
• 239000007790 solid phase Substances 0.000 abstract 1
• 238000002723 toxicity assay Methods 0.000 abstract 1
• 241000282414 Homo sapiens Species 0.000 description 343
• 108091060211 Expressed sequence tag Proteins 0.000 description 260
• 108020004999 messenger RNA Proteins 0.000 description 161
• 235000018102 proteins Nutrition 0.000 description 157
• 241000700159 Rattus Species 0.000 description 80
• 239000012634 fragment Substances 0.000 description 60
• 239000003814 drug Substances 0.000 description 59
• 229940079593 drug Drugs 0.000 description 48
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 41
• 230000001965 increasing effect Effects 0.000 description 41
• 108090000765 processed proteins & peptides Proteins 0.000 description 36
• 150000007523 nucleic acids Chemical class 0.000 description 35
• 102000039446 nucleic acids Human genes 0.000 description 33
• 108020004707 nucleic acids Proteins 0.000 description 33
• 241001465754 Metazoa Species 0.000 description 29
• 102000004196 processed proteins & peptides Human genes 0.000 description 29
• 102000005962 receptors Human genes 0.000 description 29
• 108020003175 receptors Proteins 0.000 description 29
• 241000700157 Rattus norvegicus Species 0.000 description 28
• 241000699660 Mus musculus Species 0.000 description 27
• 230000002440 hepatic effect Effects 0.000 description 26
• 210000003494 hepatocyte Anatomy 0.000 description 24
• 210000002966 serum Anatomy 0.000 description 24
• 230000000295 complement effect Effects 0.000 description 23
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 22
• 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 22
• 229920001184 polypeptide Polymers 0.000 description 22
• 229960003180 glutathione Drugs 0.000 description 21
• 238000011282 treatment Methods 0.000 description 21
• 206010028851 Necrosis Diseases 0.000 description 20
• 239000004743 Polypropylene Substances 0.000 description 20
• 230000003247 decreasing effect Effects 0.000 description 20
• 239000002158 endotoxin Substances 0.000 description 20
• 230000017074 necrotic cell death Effects 0.000 description 20
• 239000002243 precursor Substances 0.000 description 20
• 229920006008 lipopolysaccharide Polymers 0.000 description 19
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
• 101710088194 Dehydrogenase Proteins 0.000 description 17
• 230000015572 biosynthetic process Effects 0.000 description 17
• 210000003470 mitochondria Anatomy 0.000 description 17
• 108020004414 DNA Proteins 0.000 description 16
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 16
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 16
• 230000012010 growth Effects 0.000 description 16
• 229920001192 peptidylglycine Polymers 0.000 description 16
• 230000004044 response Effects 0.000 description 16
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
• 102000004190 Enzymes Human genes 0.000 description 15
• 108090000790 Enzymes Proteins 0.000 description 15
• 108010024636 Glutathione Proteins 0.000 description 15
• 108090000364 Ligases Proteins 0.000 description 15
• -1 aliphatic isothiocyanates Chemical class 0.000 description 15
• 239000002585 base Substances 0.000 description 15
• 229940088598 enzyme Drugs 0.000 description 15
• 108010003415 Aspartate Aminotransferases Proteins 0.000 description 14
• 102000004625 Aspartate Aminotransferases Human genes 0.000 description 14
• 241000699666 Mus <mouse, genus> Species 0.000 description 14
• 230000027455 binding Effects 0.000 description 14
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
• 241000282412 Homo Species 0.000 description 13
• 102000003960 Ligases Human genes 0.000 description 13
• 231100000027 toxicology Toxicity 0.000 description 13
• 108700020796 Oncogene Proteins 0.000 description 12
• 238000004458 analytical method Methods 0.000 description 12
• 238000003491 array Methods 0.000 description 12
• DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 12
• 239000002773 nucleotide Substances 0.000 description 12
• 125000003729 nucleotide group Chemical group 0.000 description 12
• 102000018832 Cytochromes Human genes 0.000 description 11
• 108010052832 Cytochromes Proteins 0.000 description 11
• 102000008109 Mixed Function Oxygenases Human genes 0.000 description 11
• 108010074633 Mixed Function Oxygenases Proteins 0.000 description 11
• 102000004316 Oxidoreductases Human genes 0.000 description 11
• 108090000854 Oxidoreductases Proteins 0.000 description 11
• 210000000941 bile Anatomy 0.000 description 11
• 230000000875 corresponding effect Effects 0.000 description 11
• 230000007423 decrease Effects 0.000 description 11
• 238000002474 experimental method Methods 0.000 description 11
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 11
• 229910052757 nitrogen Inorganic materials 0.000 description 11
• 238000010606 normalization Methods 0.000 description 11
• 229910052760 oxygen Inorganic materials 0.000 description 11
• 230000000858 peroxisomal effect Effects 0.000 description 11
• BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 10
• 230000004913 activation Effects 0.000 description 10
• 230000001154 acute effect Effects 0.000 description 10
• 108700014852 coretox Proteins 0.000 description 10
• 230000001419 dependent effect Effects 0.000 description 10
• 210000003734 kidney Anatomy 0.000 description 10
• 239000000203 mixture Substances 0.000 description 10
• 230000001105 regulatory effect Effects 0.000 description 10
• 229940035936 ubiquinone Drugs 0.000 description 10
• 230000003612 virological effect Effects 0.000 description 10
• 102000008016 Eukaryotic Initiation Factor-3 Human genes 0.000 description 9
• 108010089790 Eukaryotic Initiation Factor-3 Proteins 0.000 description 9
• 102000003886 Glycoproteins Human genes 0.000 description 9
• 108090000288 Glycoproteins Proteins 0.000 description 9
• 101150053185 P450 gene Proteins 0.000 description 9
• 102000002278 Ribosomal Proteins Human genes 0.000 description 9
• 108010000605 Ribosomal Proteins Proteins 0.000 description 9
• 230000002411 adverse Effects 0.000 description 9
• 239000000427 antigen Substances 0.000 description 9
• 210000004369 blood Anatomy 0.000 description 9
• 239000008280 blood Substances 0.000 description 9
• 239000005515 coenzyme Substances 0.000 description 9
• UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 9
• 229960000978 cyproterone acetate Drugs 0.000 description 9
• 239000003550 marker Substances 0.000 description 9
• RMLUKZWYIKEASN-UHFFFAOYSA-M sodium;2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate Chemical compound [Na+].O=C1[N-]C(N)=NC2=C1N=CN2COCCO RMLUKZWYIKEASN-UHFFFAOYSA-M 0.000 description 9
• 238000012453 sprague-dawley rat model Methods 0.000 description 9
• 239000000758 substrate Substances 0.000 description 9
• 108010078791 Carrier Proteins Proteins 0.000 description 8
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 8
• 108010071690 Prealbumin Proteins 0.000 description 8
• 241000283984 Rodentia Species 0.000 description 8
• 102000003929 Transaminases Human genes 0.000 description 8
• 108090000340 Transaminases Proteins 0.000 description 8
• 102100029290 Transthyretin Human genes 0.000 description 8
• 230000002862 amidating effect Effects 0.000 description 8
• 102000036639 antigens Human genes 0.000 description 8
• 108091007433 antigens Proteins 0.000 description 8
• 230000001413 cellular effect Effects 0.000 description 8
• 231100000673 dose–response relationship Toxicity 0.000 description 8
• 239000007788 liquid Substances 0.000 description 8
• 238000004519 manufacturing process Methods 0.000 description 8
• 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 8
• 239000002751 oligonucleotide probe Substances 0.000 description 8
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 8
• 230000035939 shock Effects 0.000 description 8
• 239000000243 solution Substances 0.000 description 8
• 238000003786 synthesis reaction Methods 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 7
• 108010082126 Alanine transaminase Proteins 0.000 description 7
• 241000271566 Aves Species 0.000 description 7
• 102000014914 Carrier Proteins Human genes 0.000 description 7
• 206010010904 Convulsion Diseases 0.000 description 7
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
• 102000004157 Hydrolases Human genes 0.000 description 7
• 108090000604 Hydrolases Proteins 0.000 description 7
• 241000699670 Mus sp. Species 0.000 description 7
• 206010028980 Neoplasm Diseases 0.000 description 7
• 102000035195 Peptidases Human genes 0.000 description 7
• 108091005804 Peptidases Proteins 0.000 description 7
• 102000037054 SLC-Transporter Human genes 0.000 description 7
• 108091006207 SLC-Transporter Proteins 0.000 description 7
• 238000002820 assay format Methods 0.000 description 7
• 108091008324 binding proteins Proteins 0.000 description 7
• 210000004556 brain Anatomy 0.000 description 7
• 230000000711 cancerogenic effect Effects 0.000 description 7
• 229910052799 carbon Inorganic materials 0.000 description 7
• 230000001939 inductive effect Effects 0.000 description 7
• 238000005259 measurement Methods 0.000 description 7
• 230000003228 microsomal effect Effects 0.000 description 7
• 238000012544 monitoring process Methods 0.000 description 7
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 7
• 238000007254 oxidation reaction Methods 0.000 description 7
• 230000000144 pharmacologic effect Effects 0.000 description 7
• 230000008929 regeneration Effects 0.000 description 7
• 238000011069 regeneration method Methods 0.000 description 7
• 229910001415 sodium ion Inorganic materials 0.000 description 7
• 230000014616 translation Effects 0.000 description 7
• ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 6
• 102100035177 Ergosterol biosynthetic protein 28 homolog Human genes 0.000 description 6
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
• 206010016654 Fibrosis Diseases 0.000 description 6
• 206010067125 Liver injury Diseases 0.000 description 6
• 102100029778 Melanoma inhibitory activity protein 2 Human genes 0.000 description 6
• 108010050808 Procollagen Proteins 0.000 description 6
• 102100032859 Protein AMBP Human genes 0.000 description 6
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
• 238000007792 addition Methods 0.000 description 6
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• 125000003118 aryl group Chemical group 0.000 description 6
• 235000012000 cholesterol Nutrition 0.000 description 6
• 208000019425 cirrhosis of liver Diseases 0.000 description 6
• 239000005516 coenzyme A Substances 0.000 description 6
• ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 6
• 235000017471 coenzyme Q10 Nutrition 0.000 description 6
• 229940093530 coenzyme a Drugs 0.000 description 6
• 229940109239 creatinine Drugs 0.000 description 6
• 230000001086 cytosolic effect Effects 0.000 description 6
• 230000006378 damage Effects 0.000 description 6
• 235000014113 dietary fatty acids Nutrition 0.000 description 6
• 229930195729 fatty acid Natural products 0.000 description 6
• 239000000194 fatty acid Substances 0.000 description 6
• 150000004665 fatty acids Chemical class 0.000 description 6
• 239000003112 inhibitor Substances 0.000 description 6
• 230000007056 liver toxicity Effects 0.000 description 6
• 230000036542 oxidative stress Effects 0.000 description 6
• 229910052700 potassium Inorganic materials 0.000 description 6
• 150000003254 radicals Chemical class 0.000 description 6
• NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 6
• 230000002829 reductive effect Effects 0.000 description 6
• 238000012216 screening Methods 0.000 description 6
• 231100000240 steatosis hepatitis Toxicity 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• 108091006112 ATPases Proteins 0.000 description 5
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 5
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 5
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 5
• 102000030782 GTP binding Human genes 0.000 description 5
• 108091000058 GTP-Binding Proteins 0.000 description 5
• 206010019837 Hepatocellular injury Diseases 0.000 description 5
• 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 5
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
• 102000002704 Leucyl aminopeptidase Human genes 0.000 description 5
• 108010004098 Leucyl aminopeptidase Proteins 0.000 description 5
• 102000016397 Methyltransferase Human genes 0.000 description 5
• 108060004795 Methyltransferase Proteins 0.000 description 5
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 5
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 5
• 108091000080 Phosphotransferase Proteins 0.000 description 5
• 102100022068 Serine palmitoyltransferase 1 Human genes 0.000 description 5
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
• 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 5
• 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 5
• 230000002378 acidificating effect Effects 0.000 description 5
• 238000010171 animal model Methods 0.000 description 5
• 230000006907 apoptotic process Effects 0.000 description 5
• 239000002299 complementary DNA Substances 0.000 description 5
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
• 230000034994 death Effects 0.000 description 5
• 230000007850 degeneration Effects 0.000 description 5
• 238000001514 detection method Methods 0.000 description 5
• 239000012530 fluid Substances 0.000 description 5
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 5
• 206010020718 hyperplasia Diseases 0.000 description 5
• 230000001771 impaired effect Effects 0.000 description 5
• 230000006698 induction Effects 0.000 description 5
• 208000032839 leukemia Diseases 0.000 description 5
• 150000002632 lipids Chemical class 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 210000004379 membrane Anatomy 0.000 description 5
• 230000001537 neural effect Effects 0.000 description 5
• 239000002245 particle Substances 0.000 description 5
• 102000020233 phosphotransferase Human genes 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 238000012545 processing Methods 0.000 description 5
• 230000002035 prolonged effect Effects 0.000 description 5
• 235000019833 protease Nutrition 0.000 description 5
• 230000008439 repair process Effects 0.000 description 5
• 150000003839 salts Chemical class 0.000 description 5
• 230000007863 steatosis Effects 0.000 description 5
• 230000002103 transcriptional effect Effects 0.000 description 5
• 150000003626 triacylglycerols Chemical class 0.000 description 5
• 229960004799 tryptophan Drugs 0.000 description 5
• 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 description 4
• KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 4
• 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 description 4
• 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 description 4
• ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 4
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
• 102000003966 Alpha-1-microglobulin Human genes 0.000 description 4
• 101800001761 Alpha-1-microglobulin Proteins 0.000 description 4
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
• 108090000663 Annexin A1 Proteins 0.000 description 4
• 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 4
• 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 4
• 102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 4
• 102000004031 Carboxy-Lyases Human genes 0.000 description 4
• 108090000489 Carboxy-Lyases Proteins 0.000 description 4
• RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 4
• 101710147944 Cytochrome b-c1 complex subunit 8 Proteins 0.000 description 4
• 230000006820 DNA synthesis Effects 0.000 description 4
• 101150114117 EGR1 gene Proteins 0.000 description 4
• 101710109047 Eukaryotic translation initiation factor 3 subunit B Proteins 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 108091006027 G proteins Proteins 0.000 description 4
• 102000016901 Glutamate dehydrogenase Human genes 0.000 description 4
• 102000005720 Glutathione transferase Human genes 0.000 description 4
• 108010070675 Glutathione transferase Proteins 0.000 description 4
• 229920002527 Glycogen Polymers 0.000 description 4
• 101001045751 Homo sapiens Hepatocyte nuclear factor 1-alpha Proteins 0.000 description 4
• 101001026554 Homo sapiens Histone H1.0 Proteins 0.000 description 4
• 101001012669 Homo sapiens Melanoma inhibitory activity protein 2 Proteins 0.000 description 4
• 101000952936 Homo sapiens Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial Proteins 0.000 description 4
• 101710144867 Inositol monophosphatase Proteins 0.000 description 4
• 101800001691 Inter-alpha-trypsin inhibitor light chain Proteins 0.000 description 4
• 206010023126 Jaundice Diseases 0.000 description 4
• 102100021395 Mortality factor 4-like protein 1 Human genes 0.000 description 4
• 238000011887 Necropsy Methods 0.000 description 4
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 4
• 108091028043 Nucleic acid sequence Proteins 0.000 description 4
• 108010077077 Osteonectin Proteins 0.000 description 4
• 102000009890 Osteonectin Human genes 0.000 description 4
• 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 4
• 102100037419 Pituitary tumor-transforming gene 1 protein-interacting protein Human genes 0.000 description 4
• 101710199379 Pituitary tumor-transforming gene 1 protein-interacting protein Proteins 0.000 description 4
• 206010060862 Prostate cancer Diseases 0.000 description 4
• 102100030706 Ras-related protein Rap-1A Human genes 0.000 description 4
• 102100025999 Rho family-interacting cell polarization regulator 1 Human genes 0.000 description 4
• 102100037220 Syndecan-4 Human genes 0.000 description 4
• 108010055215 Syndecan-4 Proteins 0.000 description 4
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 4
• 102000004271 Tryptophan 5-monooxygenases Human genes 0.000 description 4
• 108090000885 Tryptophan 5-monooxygenases Proteins 0.000 description 4
• 102000004243 Tubulin Human genes 0.000 description 4
• 108090000704 Tubulin Proteins 0.000 description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
• 102100037292 Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial Human genes 0.000 description 4
• 229910052770 Uranium Inorganic materials 0.000 description 4
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 150000001413 amino acids Chemical group 0.000 description 4
• 206010002022 amyloidosis Diseases 0.000 description 4
• 239000003855 balanced salt solution Substances 0.000 description 4
• 125000005340 bisphosphate group Chemical group 0.000 description 4
• 101150004928 bun gene Proteins 0.000 description 4
• 231100000357 carcinogen Toxicity 0.000 description 4
• 239000003183 carcinogenic agent Substances 0.000 description 4
• 238000004113 cell culture Methods 0.000 description 4
• 230000004663 cell proliferation Effects 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 4
• KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
• 238000007877 drug screening Methods 0.000 description 4
• 239000003344 environmental pollutant Substances 0.000 description 4
• 229960002568 ethinylestradiol Drugs 0.000 description 4
• 230000006870 function Effects 0.000 description 4
• 230000004927 fusion Effects 0.000 description 4
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 4
• 150000004676 glycans Chemical class 0.000 description 4
• 229940096919 glycogen Drugs 0.000 description 4
• 230000036541 health Effects 0.000 description 4
• 231100000234 hepatic damage Toxicity 0.000 description 4
• 230000008595 infiltration Effects 0.000 description 4
• 238000001764 infiltration Methods 0.000 description 4
• 229910052740 iodine Inorganic materials 0.000 description 4
• 230000003859 lipid peroxidation Effects 0.000 description 4
• 230000008818 liver damage Effects 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 230000002438 mitochondrial effect Effects 0.000 description 4
• 210000003205 muscle Anatomy 0.000 description 4
• 239000002853 nucleic acid probe Substances 0.000 description 4
• 201000008482 osteoarthritis Diseases 0.000 description 4
• 230000003647 oxidation Effects 0.000 description 4
• 230000002093 peripheral effect Effects 0.000 description 4
• 239000003614 peroxisome proliferator Substances 0.000 description 4
• 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 230000035790 physiological processes and functions Effects 0.000 description 4
• 239000000047 product Substances 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 210000001550 testis Anatomy 0.000 description 4
• 210000001541 thymus gland Anatomy 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• 210000005239 tubule Anatomy 0.000 description 4
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 3
• CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 3
• XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 3
• 102100026105 3-ketoacyl-CoA thiolase, mitochondrial Human genes 0.000 description 3
• FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 3
• 101150067539 AMBP gene Proteins 0.000 description 3
• 108010003902 Acetyl-CoA C-acyltransferase Proteins 0.000 description 3
• 101710159080 Aconitate hydratase A Proteins 0.000 description 3
• 101710159078 Aconitate hydratase B Proteins 0.000 description 3
• 102000009027 Albumins Human genes 0.000 description 3
• 108010088751 Albumins Proteins 0.000 description 3
• 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 3
• 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 3
• 101150037140 Aldoa gene Proteins 0.000 description 3
• 201000004384 Alopecia Diseases 0.000 description 3
• 102100040006 Annexin A1 Human genes 0.000 description 3
• 108010071619 Apolipoproteins Proteins 0.000 description 3
• 102000007592 Apolipoproteins Human genes 0.000 description 3
• 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 3
• 241000894006 Bacteria Species 0.000 description 3
• 108010064528 Basigin Proteins 0.000 description 3
• 102000015279 Basigin Human genes 0.000 description 3
• 108010029692 Bisphosphoglycerate mutase Proteins 0.000 description 3
• 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 3
• 102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 3
• 102000055006 Calcitonin Human genes 0.000 description 3
• 108060001064 Calcitonin Proteins 0.000 description 3
• 102000000584 Calmodulin Human genes 0.000 description 3
• 108010041952 Calmodulin Proteins 0.000 description 3
• 241000282472 Canis lupus familiaris Species 0.000 description 3
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 3
• 102100035882 Catalase Human genes 0.000 description 3
• 108010053835 Catalase Proteins 0.000 description 3
• 101150018986 Ceacam1 gene Proteins 0.000 description 3
• 102000019265 Cytochrome c1 Human genes 0.000 description 3
• 108010007528 Cytochromes c1 Proteins 0.000 description 3
• 101150071440 DDIT4L gene Proteins 0.000 description 3
• 101100339887 Drosophila melanogaster Hsp27 gene Proteins 0.000 description 3
• 102000001301 EGF receptor Human genes 0.000 description 3
• 108060006698 EGF receptor Proteins 0.000 description 3
• 102000008013 Electron Transport Complex I Human genes 0.000 description 3
• 108010089760 Electron Transport Complex I Proteins 0.000 description 3
• 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 3
• 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 3
• 208000018522 Gastrointestinal disease Diseases 0.000 description 3
• BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 3
• 108010009202 Growth Factor Receptors Proteins 0.000 description 3
• 102000009465 Growth Factor Receptors Human genes 0.000 description 3
• 101150116044 H1-0 gene Proteins 0.000 description 3
• 101150096895 HSPB1 gene Proteins 0.000 description 3
• 208000032843 Hemorrhage Diseases 0.000 description 3
• 206010019695 Hepatic neoplasm Diseases 0.000 description 3
• 108010033040 Histones Proteins 0.000 description 3
• 206010020772 Hypertension Diseases 0.000 description 3
• 206010020880 Hypertrophy Diseases 0.000 description 3
• 102000004195 Isomerases Human genes 0.000 description 3
• 108090000769 Isomerases Proteins 0.000 description 3
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 3
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 3
• LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 3
• 102100040589 Leucine-rich PPR motif-containing protein, mitochondrial Human genes 0.000 description 3
• 102000052508 Lipopolysaccharide-binding protein Human genes 0.000 description 3
• 108010053632 Lipopolysaccharide-binding protein Proteins 0.000 description 3
• 102000018697 Membrane Proteins Human genes 0.000 description 3
• 108010052285 Membrane Proteins Proteins 0.000 description 3
• 206010029164 Nephrotic syndrome Diseases 0.000 description 3
• CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 3
• 102000008299 Nitric Oxide Synthase Human genes 0.000 description 3
• 108010021487 Nitric Oxide Synthase Proteins 0.000 description 3
• 101710160107 Outer membrane protein A Proteins 0.000 description 3
• 102000011025 Phosphoglycerate Mutase Human genes 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 3
• 102000044126 RNA-Binding Proteins Human genes 0.000 description 3
• 101710105008 RNA-binding protein Proteins 0.000 description 3
• 101000651508 Rattus norvegicus 3-ketoacyl-CoA thiolase A, peroxisomal Proteins 0.000 description 3
• 101000612273 Rattus norvegicus Prenylcysteine oxidase Proteins 0.000 description 3
• 101000629598 Rattus norvegicus Sterol regulatory element-binding protein 1 Proteins 0.000 description 3
• 108700008625 Reporter Genes Proteins 0.000 description 3
• 102000000395 SH3 domains Human genes 0.000 description 3
• 108050008861 SH3 domains Proteins 0.000 description 3
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
• 102000004531 Selenoprotein P Human genes 0.000 description 3
• 108010042443 Selenoprotein P Proteins 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 101710122478 Serine palmitoyltransferase 1 Proteins 0.000 description 3
• 102100026842 Serine-pyruvate aminotransferase Human genes 0.000 description 3
• 102100031710 Splicing factor 3A subunit 3 Human genes 0.000 description 3
• 108010012901 Succinate Dehydrogenase Proteins 0.000 description 3
• 102000019259 Succinate Dehydrogenase Human genes 0.000 description 3
• 102100030552 Synaptosomal-associated protein 25 Human genes 0.000 description 3
• 102000019361 Syndecan Human genes 0.000 description 3
• 108050006774 Syndecan Proteins 0.000 description 3
• 102100040247 Tumor necrosis factor Human genes 0.000 description 3
• 102100029948 Tyrosine-protein phosphatase non-receptor type substrate 1 Human genes 0.000 description 3
• 208000025865 Ulcer Diseases 0.000 description 3
• 206010047700 Vomiting Diseases 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 229940024606 amino acid Drugs 0.000 description 3
• 235000001014 amino acid Nutrition 0.000 description 3
• 230000002280 anti-androgenic effect Effects 0.000 description 3
• 230000003110 anti-inflammatory effect Effects 0.000 description 3
• 239000000051 antiandrogen Substances 0.000 description 3
• 239000002221 antipyretic Substances 0.000 description 3
• 210000000013 bile duct Anatomy 0.000 description 3
• 239000012472 biological sample Substances 0.000 description 3
• 230000036983 biotransformation Effects 0.000 description 3
• 210000000988 bone and bone Anatomy 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 3
• 229960004015 calcitonin Drugs 0.000 description 3
• 238000004364 calculation method Methods 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 239000004202 carbamide Substances 0.000 description 3
• 230000030833 cell death Effects 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 101150055214 cyp1a1 gene Proteins 0.000 description 3
• 238000000151 deposition Methods 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 3
• 230000002449 erythroblastic effect Effects 0.000 description 3
• 230000029142 excretion Effects 0.000 description 3
• 229910052731 fluorine Inorganic materials 0.000 description 3
• 230000002496 gastric effect Effects 0.000 description 3
• 210000001035 gastrointestinal tract Anatomy 0.000 description 3
• 150000003278 haem Chemical class 0.000 description 3
• 210000002216 heart Anatomy 0.000 description 3
• 231100000753 hepatic injury Toxicity 0.000 description 3
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
• 231100000437 hepatocellular injury Toxicity 0.000 description 3
• 229910052739 hydrogen Inorganic materials 0.000 description 3
• 239000000411 inducer Substances 0.000 description 3
• 229940058690 lanosterol Drugs 0.000 description 3
• CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 3
• 231100000832 liver cell necrosis Toxicity 0.000 description 3
• 230000007774 longterm Effects 0.000 description 3
• 239000006166 lysate Substances 0.000 description 3
• 238000012423 maintenance Methods 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 239000002207 metabolite Substances 0.000 description 3
• 230000011987 methylation Effects 0.000 description 3
• 238000007069 methylation reaction Methods 0.000 description 3
• 230000000394 mitotic effect Effects 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 231100000956 nontoxicity Toxicity 0.000 description 3
• 238000007899 nucleic acid hybridization Methods 0.000 description 3
• 239000002777 nucleoside Substances 0.000 description 3
• 238000002966 oligonucleotide array Methods 0.000 description 3
• 229960005489 paracetamol Drugs 0.000 description 3
• 230000001575 pathological effect Effects 0.000 description 3
• 239000000575 pesticide Substances 0.000 description 3
• 108010025593 phenylalanine (histidine) aminotransferase Proteins 0.000 description 3
• KCRZDTROFIOPBP-UHFFFAOYSA-N phosphono 2,3-dihydroxypropanoate Chemical compound OCC(O)C(=O)OP(O)(O)=O KCRZDTROFIOPBP-UHFFFAOYSA-N 0.000 description 3
• 150000008300 phosphoramidites Chemical class 0.000 description 3
• 150000003180 prostaglandins Chemical class 0.000 description 3
• 238000001243 protein synthesis Methods 0.000 description 3
• 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 210000005084 renal tissue Anatomy 0.000 description 3
• 230000002441 reversible effect Effects 0.000 description 3
• 108010060800 serine-pyruvate aminotransferase Proteins 0.000 description 3
• 229940076279 serotonin Drugs 0.000 description 3
• 230000011664 signaling Effects 0.000 description 3
• 239000002904 solvent Substances 0.000 description 3
• 241000894007 species Species 0.000 description 3
• 108010022412 splicing factor 3a Proteins 0.000 description 3
• 230000008961 swelling Effects 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• 230000014621 translational initiation Effects 0.000 description 3
• 229910052721 tungsten Inorganic materials 0.000 description 3
• 210000000689 upper leg Anatomy 0.000 description 3
• 230000003827 upregulation Effects 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
• 101710091323 26S proteasome non-ATPase regulatory subunit 5 Proteins 0.000 description 2
• 102100033453 26S proteasome non-ATPase regulatory subunit 5 Human genes 0.000 description 2
• 102100028830 28S ribosomal protein S25, mitochondrial Human genes 0.000 description 2
• KYQCXUMVJGMDNG-UHFFFAOYSA-N 4,5,6,7,8-pentahydroxy-2-oxooctanoic acid Chemical compound OCC(O)C(O)C(O)C(O)CC(=O)C(O)=O KYQCXUMVJGMDNG-UHFFFAOYSA-N 0.000 description 2
• 102100031928 40S ribosomal protein S29 Human genes 0.000 description 2
• 102100021690 60S ribosomal protein L18a Human genes 0.000 description 2
• 101150106303 AHSG gene Proteins 0.000 description 2
• 101150020529 APOA4 gene Proteins 0.000 description 2
• 101150001527 APOC3 gene Proteins 0.000 description 2
• 101150072179 ATP1 gene Proteins 0.000 description 2
• 101150054866 Acadl gene Proteins 0.000 description 2
• 102100033639 Acetylcholinesterase Human genes 0.000 description 2
• 108010022752 Acetylcholinesterase Proteins 0.000 description 2
• 208000003200 Adenoma Diseases 0.000 description 2
• 102100034033 Alpha-adducin Human genes 0.000 description 2
• 102100040410 Alpha-methylacyl-CoA racemase Human genes 0.000 description 2
• 108010044434 Alpha-methylacyl-CoA racemase Proteins 0.000 description 2
• 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 2
• 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 2
• 108050005273 Amino acid transporters Proteins 0.000 description 2
• 102000034263 Amino acid transporters Human genes 0.000 description 2
• 102100022417 Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 Human genes 0.000 description 2
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
• 208000019901 Anxiety disease Diseases 0.000 description 2
• 102100037320 Apolipoprotein A-IV Human genes 0.000 description 2
• 102000030169 Apolipoprotein C-III Human genes 0.000 description 2
• 108010056301 Apolipoprotein C-III Proteins 0.000 description 2
• 102400000059 Arg-vasopressin Human genes 0.000 description 2
• 101800001144 Arg-vasopressin Proteins 0.000 description 2
• BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
• 206010003694 Atrophy Diseases 0.000 description 2
• 102100030802 Beta-2-glycoprotein 1 Human genes 0.000 description 2
• 102100038451 CDK5 regulatory subunit-associated protein 2 Human genes 0.000 description 2
• 102100027674 CTD small phosphatase-like protein Human genes 0.000 description 2
• 101150117450 CYP1A2 gene Proteins 0.000 description 2
• 101150016254 CYP51A1 gene Proteins 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
• 206010007269 Carcinogenicity Diseases 0.000 description 2
• 201000009030 Carcinoma Diseases 0.000 description 2
• 102000008122 Casein Kinase I Human genes 0.000 description 2
• 108010049812 Casein Kinase I Proteins 0.000 description 2
• 102000005483 Cell Cycle Proteins Human genes 0.000 description 2
• 108010031896 Cell Cycle Proteins Proteins 0.000 description 2
• 102100032860 Cell division cycle 5-like protein Human genes 0.000 description 2
• 101710181166 Centrosomin Proteins 0.000 description 2
• 108010059013 Chaperonin 10 Proteins 0.000 description 2
• 206010010071 Coma Diseases 0.000 description 2
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
• 241000699800 Cricetinae Species 0.000 description 2
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
• 108050006400 Cyclin Proteins 0.000 description 2
• 102000015833 Cystatin Human genes 0.000 description 2
• 101710146285 Cytochrome b-c1 complex subunit 6, mitochondrial Proteins 0.000 description 2
• 102100029861 Cytochrome b-c1 complex subunit 8 Human genes 0.000 description 2
• 102400000011 Cytochrome b-c1 complex subunit 9 Human genes 0.000 description 2
• 101800000778 Cytochrome b-c1 complex subunit 9 Proteins 0.000 description 2
• 102100028005 Cytochrome b-c1 complex subunit 9 Human genes 0.000 description 2
• 230000005778 DNA damage Effects 0.000 description 2
• 231100000277 DNA damage Toxicity 0.000 description 2
• 206010011953 Decreased activity Diseases 0.000 description 2
• 206010012735 Diarrhoea Diseases 0.000 description 2
• 102000003857 Dolichyl-phosphate beta-glucosyltransferases Human genes 0.000 description 2
• 108090000224 Dolichyl-phosphate beta-glucosyltransferases Proteins 0.000 description 2
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
• 101150059079 EBNA1 gene Proteins 0.000 description 2
• 102100030209 Elongin-B Human genes 0.000 description 2
• 108700039887 Essential Genes Proteins 0.000 description 2
• 101710109043 Eukaryotic translation initiation factor 3 subunit A Proteins 0.000 description 2
• 102100021699 Eukaryotic translation initiation factor 3 subunit B Human genes 0.000 description 2
• 102100035045 Eukaryotic translation initiation factor 3 subunit C Human genes 0.000 description 2
• 101710109030 Eukaryotic translation initiation factor 3 subunit C Proteins 0.000 description 2
• 206010015548 Euthanasia Diseases 0.000 description 2
• 208000010201 Exanthema Diseases 0.000 description 2
• 102100038980 Exosome complex component CSL4 Human genes 0.000 description 2
• 101710103768 Fatty acid-binding protein 1, liver Proteins 0.000 description 2
• 102100026745 Fatty acid-binding protein, liver Human genes 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 102000003983 Flavoproteins Human genes 0.000 description 2
• 108010057573 Flavoproteins Proteins 0.000 description 2
• 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 description 2
• 101150004913 GAMT gene Proteins 0.000 description 2
• 108090000926 GMP synthase (glutamine-hydrolyzing) Proteins 0.000 description 2
• 102100033452 GMP synthase [glutamine-hydrolyzing] Human genes 0.000 description 2
• 102100037156 Gap junction beta-2 protein Human genes 0.000 description 2
• 101710198067 Gap junction beta-2 protein Proteins 0.000 description 2
• JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108010051724 Glycine-tRNA Ligase Proteins 0.000 description 2
• 102000007390 Glycogen Phosphorylase Human genes 0.000 description 2
• 108010046163 Glycogen Phosphorylase Proteins 0.000 description 2
• 201000005569 Gout Diseases 0.000 description 2
• 108010010234 HDL Lipoproteins Proteins 0.000 description 2
• 102000015779 HDL Lipoproteins Human genes 0.000 description 2
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 description 2
• 108010058607 HLA-B Antigens Proteins 0.000 description 2
• 101150015707 HTR1A gene Proteins 0.000 description 2
• 108050006318 Haem oxygenases Proteins 0.000 description 2
• 102000016761 Haem oxygenases Human genes 0.000 description 2
• 206010019233 Headaches Diseases 0.000 description 2
• 206010019663 Hepatic failure Diseases 0.000 description 2
• 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 2
• RPTUSVTUFVMDQK-UHFFFAOYSA-N Hidralazin Chemical compound C1=CC=C2C(NN)=NN=CC2=C1 RPTUSVTUFVMDQK-UHFFFAOYSA-N 0.000 description 2
• 102100037487 Histone H1.0 Human genes 0.000 description 2
• 101000980303 Homo sapiens 10 kDa heat shock protein, mitochondrial Proteins 0.000 description 2
• 101000858479 Homo sapiens 28S ribosomal protein S25, mitochondrial Proteins 0.000 description 2
• 101000799076 Homo sapiens Alpha-adducin Proteins 0.000 description 2
• 101000725950 Homo sapiens CTD small phosphatase-like protein Proteins 0.000 description 2
• 101000868318 Homo sapiens Cell division cycle 5-like protein Proteins 0.000 description 2
• 101001011859 Homo sapiens Elongin-A Proteins 0.000 description 2
• 101001011846 Homo sapiens Elongin-B Proteins 0.000 description 2
• 101000881731 Homo sapiens Elongin-C Proteins 0.000 description 2
• 101000876557 Homo sapiens Ergosterol biosynthetic protein 28 homolog Proteins 0.000 description 2
• 101000882169 Homo sapiens Exosome complex component CSL4 Proteins 0.000 description 2
• 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 description 2
• 101100237512 Homo sapiens MIA2 gene Proteins 0.000 description 2
• 101100291759 Homo sapiens MORF4L1 gene Proteins 0.000 description 2
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
• 101000662112 Homo sapiens Pre-mRNA-splicing factor SYF2 Proteins 0.000 description 2
• 101001015936 Homo sapiens Probable rRNA-processing protein EBP2 Proteins 0.000 description 2
• 101100413188 Homo sapiens RIPOR1 gene Proteins 0.000 description 2
• 101000584595 Homo sapiens Ras-related protein Rap-1A Proteins 0.000 description 2
• 101001112293 Homo sapiens Retinoic acid receptor alpha Proteins 0.000 description 2
• 101000575667 Homo sapiens Rho family-interacting cell polarization regulator 1 Proteins 0.000 description 2
• 101000836005 Homo sapiens S-phase kinase-associated protein 1 Proteins 0.000 description 2
• 101000881168 Homo sapiens SPARC Proteins 0.000 description 2
• 101150082797 Hspe1 gene Proteins 0.000 description 2
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 102000004867 Hydro-Lyases Human genes 0.000 description 2
• 108090001042 Hydro-Lyases Proteins 0.000 description 2
• 206010020649 Hyperkeratosis Diseases 0.000 description 2
• 101150050263 ICAM1 gene Proteins 0.000 description 2
• 101150009635 IGFBP3 gene Proteins 0.000 description 2
• 102100036340 Importin-5 Human genes 0.000 description 2
• 101710125769 Importin-5 Proteins 0.000 description 2
• 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 description 2
• 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 description 2
• 102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 description 2
• 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 2
• 102100036981 Interferon regulatory factor 1 Human genes 0.000 description 2
• 108090000890 Interferon regulatory factor 1 Proteins 0.000 description 2
• 102000006541 Ionotropic Glutamate Receptors Human genes 0.000 description 2
• 108010008812 Ionotropic Glutamate Receptors Proteins 0.000 description 2
• 108010044467 Isoenzymes Proteins 0.000 description 2
• 108010077861 Kininogens Proteins 0.000 description 2
• 102000010631 Kininogens Human genes 0.000 description 2
• 108010007622 LDL Lipoproteins Proteins 0.000 description 2
• 102000007330 LDL Lipoproteins Human genes 0.000 description 2
• 101710099853 Leucine-rich PPR motif-containing protein, mitochondrial Proteins 0.000 description 2
• 108010031801 Lipopolysaccharide Receptors Proteins 0.000 description 2
• 102000005482 Lipopolysaccharide Receptors Human genes 0.000 description 2
• 102000018653 Long-Chain Acyl-CoA Dehydrogenase Human genes 0.000 description 2
• 108010027062 Long-Chain Acyl-CoA Dehydrogenase Proteins 0.000 description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
• 108010092041 Lysine-tRNA Ligase Proteins 0.000 description 2
• 102100035529 Lysine-tRNA ligase Human genes 0.000 description 2
• WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
• 102000000562 Monocarboxylic Acid Transporters Human genes 0.000 description 2
• 101710204259 Monocarboxylic acid transporter Proteins 0.000 description 2
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
• 108050006265 Mortality factor 4-like protein 1 Proteins 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• URNSECGXFRDEDC-UHFFFAOYSA-N N-acetyl-1,4-benzoquinone imine Chemical compound CC(=O)N=C1C=CC(=O)C=C1 URNSECGXFRDEDC-UHFFFAOYSA-N 0.000 description 2
• 102100036713 N-acetylglucosamine-1-phosphotransferase subunit gamma Human genes 0.000 description 2
• 108010086428 NADH Dehydrogenase Proteins 0.000 description 2
• 102000006746 NADH Dehydrogenase Human genes 0.000 description 2
• 102100023212 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Human genes 0.000 description 2
• 101710179763 NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial Proteins 0.000 description 2
• 102000004722 NADPH Oxidases Human genes 0.000 description 2
• 108010002998 NADPH Oxidases Proteins 0.000 description 2
• 206010028813 Nausea Diseases 0.000 description 2
• 102000007999 Nuclear Proteins Human genes 0.000 description 2
• 108010089610 Nuclear Proteins Proteins 0.000 description 2
• 102100029102 Nucleolar protein 16 Human genes 0.000 description 2
• 102000002488 Nucleoplasmin Human genes 0.000 description 2
• 101150010646 ODC1 gene Proteins 0.000 description 2
• 208000002193 Pain Diseases 0.000 description 2
• 102100034078 Phosphofurin acidic cluster sorting protein 1 Human genes 0.000 description 2
• 101710135643 Phosphofurin acidic cluster sorting protein 1 Proteins 0.000 description 2
• 102000007982 Phosphoproteins Human genes 0.000 description 2
• 108010089430 Phosphoproteins Proteins 0.000 description 2
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 2
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 2
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 2
• 101000640376 Plasmodium falciparum (isolate 3D7) Signal peptidase complex catalytic subunit SEC11 Proteins 0.000 description 2
• 102100034955 Poly(rC)-binding protein 3 Human genes 0.000 description 2
• 101710089648 Poly(rC)-binding protein 3 Proteins 0.000 description 2
• 101000621511 Potato virus M (strain German) RNA silencing suppressor Proteins 0.000 description 2
• 102100032223 Probable rRNA-processing protein EBP2 Human genes 0.000 description 2
• 108010049404 Prokaryotic Initiation Factor-3 Proteins 0.000 description 2
• 102100040659 Prolargin Human genes 0.000 description 2
• 101710117467 Prolargin Proteins 0.000 description 2
• 102100036691 Proliferating cell nuclear antigen Human genes 0.000 description 2
• 102100026126 Proline-tRNA ligase Human genes 0.000 description 2
• 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
• 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 101710180316 Protease 2 Proteins 0.000 description 2
• 108010029485 Protein Isoforms Proteins 0.000 description 2
• 102000001708 Protein Isoforms Human genes 0.000 description 2
• 102100036351 Protein disulfide-isomerase A2 Human genes 0.000 description 2
• 101710106238 Protein disulfide-isomerase A2 Proteins 0.000 description 2
• 102000052575 Proto-Oncogene Human genes 0.000 description 2
• 108700020978 Proto-Oncogene Proteins 0.000 description 2
• 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 2
• 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 2
• 108020005115 Pyruvate Kinase Proteins 0.000 description 2
• 102000013009 Pyruvate Kinase Human genes 0.000 description 2
• 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 2
• 101150101372 RAF1 gene Proteins 0.000 description 2
• 101100214466 Rattus norvegicus Zwint gene Proteins 0.000 description 2
• 208000001647 Renal Insufficiency Diseases 0.000 description 2
• 208000006265 Renal cell carcinoma Diseases 0.000 description 2
• 206010038540 Renal tubular necrosis Diseases 0.000 description 2
• 102100023606 Retinoic acid receptor alpha Human genes 0.000 description 2
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
• 102000014126 RuvB-like Human genes 0.000 description 2
• 108050003989 RuvB-like Proteins 0.000 description 2
• 101150095449 SDC4 gene Proteins 0.000 description 2
• 101150077859 SEC11C gene Proteins 0.000 description 2
• 102100037599 SPARC Human genes 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 206010039897 Sedation Diseases 0.000 description 2
• 102000004563 Selenoprotein W Human genes 0.000 description 2
• 108010042538 Selenoprotein W Proteins 0.000 description 2
• 108010024814 Serine C-palmitoyltransferase Proteins 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
• 102100038626 Sorting nexin-6 Human genes 0.000 description 2
• 102100021817 Splicing factor 3B subunit 6 Human genes 0.000 description 2
• 229930182558 Sterol Natural products 0.000 description 2
• 102100025393 Succinate dehydrogenase cytochrome b560 subunit, mitochondrial Human genes 0.000 description 2
• 101710142922 Succinate dehydrogenase cytochrome b560 subunit, mitochondrial Proteins 0.000 description 2
• 108010057722 Synaptosomal-Associated Protein 25 Proteins 0.000 description 2
• 108700012920 TNF Proteins 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 102100023132 Transcription factor Jun Human genes 0.000 description 2
• 102000004357 Transferases Human genes 0.000 description 2
• 108090000992 Transferases Proteins 0.000 description 2
• 206010044565 Tremor Diseases 0.000 description 2
• 102000002501 Tryptophan-tRNA Ligase Human genes 0.000 description 2
• 102100034302 Tryptophan-tRNA ligase, mitochondrial Human genes 0.000 description 2
• 101710183617 Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 description 2
• HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 2
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 2
• 102100038834 UTP-glucose-1-phosphate uridylyltransferase Human genes 0.000 description 2
• 102100038466 Ubiquitin-conjugating enzyme E2 R1 Human genes 0.000 description 2
• 206010064996 Ulcerative keratitis Diseases 0.000 description 2
• HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 2
• 102000003848 Uteroglobin Human genes 0.000 description 2
• 108090000203 Uteroglobin Proteins 0.000 description 2
• 108010062497 VLDL Lipoproteins Proteins 0.000 description 2
• 102000011731 Vacuolar Proton-Translocating ATPases Human genes 0.000 description 2
• 108010037026 Vacuolar Proton-Translocating ATPases Proteins 0.000 description 2
• 102100039746 WASH complex subunit 3 Human genes 0.000 description 2
• IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 2
• 230000005856 abnormality Effects 0.000 description 2
• 230000035508 accumulation Effects 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 229940022698 acetylcholinesterase Drugs 0.000 description 2
• 229960001138 acetylsalicylic acid Drugs 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 108010075843 alpha-2-HS-Glycoprotein Proteins 0.000 description 2
• 102000012005 alpha-2-HS-Glycoprotein Human genes 0.000 description 2
• 229940043215 aminolevulinate Drugs 0.000 description 2
• 229960002749 aminolevulinic acid Drugs 0.000 description 2
• 229910021529 ammonia Inorganic materials 0.000 description 2
• 230000000202 analgesic effect Effects 0.000 description 2
• 239000000730 antalgic agent Substances 0.000 description 2
• 230000001754 anti-pyretic effect Effects 0.000 description 2
• 239000003524 antilipemic agent Substances 0.000 description 2
• 239000003963 antioxidant agent Substances 0.000 description 2
• 235000006708 antioxidants Nutrition 0.000 description 2
• 108010073614 apolipoprotein A-IV Proteins 0.000 description 2
• YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
• KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 2
• 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
• 230000037444 atrophy Effects 0.000 description 2
• 108010023562 beta 2-Glycoprotein I Proteins 0.000 description 2
• 208000036815 beta tubulin Diseases 0.000 description 2
• 239000003833 bile salt Substances 0.000 description 2
• 208000034158 bleeding Diseases 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 208000002352 blister Diseases 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 102100029168 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human genes 0.000 description 2
• 231100000315 carcinogenic Toxicity 0.000 description 2
• 231100000260 carcinogenicity Toxicity 0.000 description 2
• 230000007670 carcinogenicity Effects 0.000 description 2
• 230000000747 cardiac effect Effects 0.000 description 2
• 229960004203 carnitine Drugs 0.000 description 2
• 230000003197 catalytic effect Effects 0.000 description 2
• 230000022131 cell cycle Effects 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 230000001713 cholinergic effect Effects 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 230000007882 cirrhosis Effects 0.000 description 2
• 230000009850 completed effect Effects 0.000 description 2
• 239000002131 composite material Substances 0.000 description 2
• 230000036461 convulsion Effects 0.000 description 2
• 229910052802 copper Inorganic materials 0.000 description 2
• 239000010949 copper Substances 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
• 229940095074 cyclic amp Drugs 0.000 description 2
• 108050004038 cystatin Proteins 0.000 description 2
• 230000006743 cytoplasmic accumulation Effects 0.000 description 2
• 231100000135 cytotoxicity Toxicity 0.000 description 2
• 230000003013 cytotoxicity Effects 0.000 description 2
• 238000007418 data mining Methods 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 230000036425 denaturation Effects 0.000 description 2
• 238000004925 denaturation Methods 0.000 description 2
• 230000008021 deposition Effects 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 230000001627 detrimental effect Effects 0.000 description 2
• 235000005911 diet Nutrition 0.000 description 2
• 230000037213 diet Effects 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 235000011180 diphosphates Nutrition 0.000 description 2
• XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
• 210000001038 distal kidney tubule Anatomy 0.000 description 2
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 238000009509 drug development Methods 0.000 description 2
• 239000003596 drug target Substances 0.000 description 2
• 201000006549 dyspepsia Diseases 0.000 description 2
• 230000009762 endothelial cell differentiation Effects 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 201000005884 exanthem Diseases 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 210000001508 eye Anatomy 0.000 description 2
• 208000010706 fatty liver disease Diseases 0.000 description 2
• 102000013361 fetuin Human genes 0.000 description 2
• 108060002885 fetuin Proteins 0.000 description 2
• 230000004761 fibrosis Effects 0.000 description 2
• 235000013305 food Nutrition 0.000 description 2
• 238000013467 fragmentation Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 239000000446 fuel Substances 0.000 description 2
• 125000000524 functional group Chemical group 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 239000008103 glucose Substances 0.000 description 2
• 210000003714 granulocyte Anatomy 0.000 description 2
• 208000024963 hair loss Diseases 0.000 description 2
• 230000003676 hair loss Effects 0.000 description 2
• 231100000869 headache Toxicity 0.000 description 2
• 230000004730 hepatocarcinogenesis Effects 0.000 description 2
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
• 231100000334 hepatotoxic Toxicity 0.000 description 2
• 230000003082 hepatotoxic effect Effects 0.000 description 2
• 230000036732 histological change Effects 0.000 description 2
• 238000002657 hormone replacement therapy Methods 0.000 description 2
• 102000005438 human GCIP-interacting protein p29 Human genes 0.000 description 2
• 238000005805 hydroxylation reaction Methods 0.000 description 2
• 231100000580 in vitro toxicity testing Toxicity 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 238000011221 initial treatment Methods 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 229960000367 inositol Drugs 0.000 description 2
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
• 102000006029 inositol monophosphatase Human genes 0.000 description 2
• 206010022437 insomnia Diseases 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 201000006370 kidney failure Diseases 0.000 description 2
• 210000001865 kupffer cell Anatomy 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 208000007903 liver failure Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 238000007477 logistic regression Methods 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 201000005202 lung cancer Diseases 0.000 description 2
• 208000020816 lung neoplasm Diseases 0.000 description 2
• 229940118019 malondialdehyde Drugs 0.000 description 2
• 230000008774 maternal effect Effects 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• 239000003226 mitogen Substances 0.000 description 2
• 230000002297 mitogenic effect Effects 0.000 description 2
• 230000000877 morphologic effect Effects 0.000 description 2
• 230000003551 muscarinic effect Effects 0.000 description 2
• 108700024542 myc Genes Proteins 0.000 description 2
• 230000008693 nausea Effects 0.000 description 2
• 230000001338 necrotic effect Effects 0.000 description 2
• 208000009928 nephrosis Diseases 0.000 description 2
• 231100001027 nephrosis Toxicity 0.000 description 2
• 231100000417 nephrotoxicity Toxicity 0.000 description 2
• 230000004770 neurodegeneration Effects 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 239000002547 new drug Substances 0.000 description 2
• 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
• BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
• 230000009871 nonspecific binding Effects 0.000 description 2
• 101150083701 npm1 gene Proteins 0.000 description 2
• 108060005597 nucleoplasmin Proteins 0.000 description 2
• 150000003833 nucleoside derivatives Chemical class 0.000 description 2
• 239000003960 organic solvent Substances 0.000 description 2
• 230000004783 oxidative metabolism Effects 0.000 description 2
• 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
• 230000036407 pain Effects 0.000 description 2
• 210000004738 parenchymal cell Anatomy 0.000 description 2
• 230000008506 pathogenesis Effects 0.000 description 2
• 239000008177 pharmaceutical agent Substances 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
• 102000030592 phosphoserine aminotransferase Human genes 0.000 description 2
• 108010088694 phosphoserine aminotransferase Proteins 0.000 description 2
• 239000002504 physiological saline solution Substances 0.000 description 2
• 230000036470 plasma concentration Effects 0.000 description 2
• 231100000719 pollutant Toxicity 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 229920001282 polysaccharide Polymers 0.000 description 2
• 239000005017 polysaccharide Substances 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 210000000512 proximal kidney tubule Anatomy 0.000 description 2
• 101150053856 psmb9 gene Proteins 0.000 description 2
• 108700042226 ras Genes Proteins 0.000 description 2
• 102000016914 ras Proteins Human genes 0.000 description 2
• 206010037844 rash Diseases 0.000 description 2
• 239000012048 reactive intermediate Substances 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000001172 regenerating effect Effects 0.000 description 2
• 230000008085 renal dysfunction Effects 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• 108010019034 ribosomal protein L18a Proteins 0.000 description 2
• 108010093173 ribosomal protein S29 Proteins 0.000 description 2
• 210000003705 ribosome Anatomy 0.000 description 2
• 238000005070 sampling Methods 0.000 description 2
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
• 230000036280 sedation Effects 0.000 description 2
• 231100000161 signs of toxicity Toxicity 0.000 description 2
• 101150080510 snap25 gene Proteins 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 238000013222 sprague-dawley male rat Methods 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 150000003431 steroids Chemical class 0.000 description 2
• 150000003432 sterols Chemical class 0.000 description 2
• 235000003702 sterols Nutrition 0.000 description 2
• 229910052717 sulfur Inorganic materials 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• 230000017423 tissue regeneration Effects 0.000 description 2
• 231100000167 toxic agent Toxicity 0.000 description 2
• 231100000563 toxic property Toxicity 0.000 description 2
• 231100000041 toxicology testing Toxicity 0.000 description 2
• 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 2
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
• 239000000717 tumor promoter Substances 0.000 description 2
• 231100000397 ulcer Toxicity 0.000 description 2
• 230000036269 ulceration Effects 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 229910052720 vanadium Inorganic materials 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 150000003722 vitamin derivatives Chemical class 0.000 description 2
• 230000008673 vomiting Effects 0.000 description 2
• 101150076297 ywhaz gene Proteins 0.000 description 2
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
• OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• KHWTYGFHPHRQMP-UHFFFAOYSA-N (4-propan-2-ylcyclohexyl)methanol Chemical compound CC(C)C1CCC(CO)CC1 KHWTYGFHPHRQMP-UHFFFAOYSA-N 0.000 description 1
• 108091064702 1 family Proteins 0.000 description 1
• WKKCYLSCLQVWFD-UHFFFAOYSA-N 1,2-dihydropyrimidin-4-amine Chemical compound N=C1NCNC=C1 WKKCYLSCLQVWFD-UHFFFAOYSA-N 0.000 description 1
• VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 description 1
• WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
• SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
• DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 description 1
• ZEYRDXUWJDGTLD-UHFFFAOYSA-N 2-(2-ethyl-5-methoxy-1h-indol-3-yl)-n,n-dimethylethanamine Chemical compound C1=C(OC)C=C2C(CCN(C)C)=C(CC)NC2=C1 ZEYRDXUWJDGTLD-UHFFFAOYSA-N 0.000 description 1
• 239000003315 2-(4-chlorophenoxy)-2-methylpropanoic acid Substances 0.000 description 1
• SXERGJJQSKIUIC-UHFFFAOYSA-N 2-Phenoxypropionic acid Chemical class OC(=O)C(C)OC1=CC=CC=C1 SXERGJJQSKIUIC-UHFFFAOYSA-N 0.000 description 1
• JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
• QDJSZVRLBGARTP-UHFFFAOYSA-N 2-cyclopropylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1CC1 QDJSZVRLBGARTP-UHFFFAOYSA-N 0.000 description 1
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
• HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 1
• 102100036652 26S proteasome non-ATPase regulatory subunit 8 Human genes 0.000 description 1
• 101710099475 3'-phosphoadenosine 5'-phosphate phosphatase Proteins 0.000 description 1
• WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
• 102100033751 39S ribosomal protein L49, mitochondrial Human genes 0.000 description 1
• 101710180042 39kDa core protein Proteins 0.000 description 1
• 108010060511 4-Aminobutyrate Transaminase Proteins 0.000 description 1
• LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 1
• 102100035923 4-aminobutyrate aminotransferase, mitochondrial Human genes 0.000 description 1
• 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
• 101710131798 40S ribosomal protein S28 Proteins 0.000 description 1
• 102100022600 40S ribosomal protein S3a Human genes 0.000 description 1
• 102000004008 5'-Nucleotidase Human genes 0.000 description 1
• 102100022464 5'-nucleotidase Human genes 0.000 description 1
• 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 description 1
• AZUVBPVDRHGGEP-UHFFFAOYSA-N 6a,9a-dimethyl-4,5,7,8,9,9a-hexahydro-6aH-dipyrrolo(2,3-b;3',2',1'-hi)indole Natural products CC(=C)C1CCC(C)=CCCC(C)=CCCC(C)=CC1O AZUVBPVDRHGGEP-UHFFFAOYSA-N 0.000 description 1
• ULGJWNIHLSLQPZ-UHFFFAOYSA-N 7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-n-[2-(1h-indol-3-yl)ethyl]heptanamide Chemical compound C1CCCC2=NC3=CC(Cl)=CC(Cl)=C3C(NCCCCCCC(=O)NCCC=3C4=CC=CC=C4NC=3)=C21 ULGJWNIHLSLQPZ-UHFFFAOYSA-N 0.000 description 1
• 102000009067 AAA Proteins Human genes 0.000 description 1
• 108010087671 AAA Proteins Proteins 0.000 description 1
• 101150083548 ABCC2 gene Proteins 0.000 description 1
• 229940124596 AChE inhibitor Drugs 0.000 description 1
• 102000000074 ADP-ribosyl Cyclase Human genes 0.000 description 1
• 108010080394 ADP-ribosyl Cyclase Proteins 0.000 description 1
• 108010027122 ADP-ribosyl Cyclase 1 Proteins 0.000 description 1
• 102000018667 ADP-ribosyl Cyclase 1 Human genes 0.000 description 1
• 102000020236 ADP-ribosylarginine hydrolase Human genes 0.000 description 1
• 108010079768 ADP-ribosylarginine hydrolase Proteins 0.000 description 1
• 101150082527 ALAD gene Proteins 0.000 description 1
• 102100040799 AN1-type zinc finger protein 3 Human genes 0.000 description 1
• 101150008694 ANXA1 gene Proteins 0.000 description 1
• 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
• 102100028161 ATP-binding cassette sub-family C member 2 Human genes 0.000 description 1
• 102100022284 ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Human genes 0.000 description 1
• 102100021405 ATP-dependent RNA helicase DDX1 Human genes 0.000 description 1
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
• 101150090751 ATP6V1F gene Proteins 0.000 description 1
• 208000004998 Abdominal Pain Diseases 0.000 description 1
• 208000002874 Acne Vulgaris Diseases 0.000 description 1
• 102000004373 Actin-related protein 2 Human genes 0.000 description 1
• 108090000963 Actin-related protein 2 Proteins 0.000 description 1
• 102100021636 Actin-related protein 2/3 complex subunit 2 Human genes 0.000 description 1
• 101710183444 Actin-related protein 2/3 complex subunit 2 Proteins 0.000 description 1
• 102000003741 Actin-related protein 3 Human genes 0.000 description 1
• 108090000104 Actin-related protein 3 Proteins 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 206010048998 Acute phase reaction Diseases 0.000 description 1
• 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
• 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
• 102000057234 Acyl transferases Human genes 0.000 description 1
• 108700016155 Acyl transferases Proteins 0.000 description 1
• 102000002735 Acyl-CoA Dehydrogenase Human genes 0.000 description 1
• 108010001058 Acyl-CoA Dehydrogenase Proteins 0.000 description 1
• 102000002296 Acyl-CoA Dehydrogenases Human genes 0.000 description 1
• 102000004539 Acyl-CoA Oxidase Human genes 0.000 description 1
• 108020001558 Acyl-CoA oxidase Proteins 0.000 description 1
• 206010001233 Adenoma benign Diseases 0.000 description 1
• 108010056443 Adenylosuccinate synthase Proteins 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 102100036092 Alpha-endosulfine Human genes 0.000 description 1
• 206010002091 Anaesthesia Diseases 0.000 description 1
• 102000008873 Angiotensin II receptor Human genes 0.000 description 1
• 108050000824 Angiotensin II receptor Proteins 0.000 description 1
• 102000011399 Anion exchange proteins Human genes 0.000 description 1
• 108050001632 Anion exchange proteins Proteins 0.000 description 1
• 102000000412 Annexin Human genes 0.000 description 1
• 108050008874 Annexin Proteins 0.000 description 1
• 102000004145 Annexin A1 Human genes 0.000 description 1
• 101150007356 Apoc1 gene Proteins 0.000 description 1
• 102000011772 Apolipoprotein C-I Human genes 0.000 description 1
• 108010076807 Apolipoprotein C-I Proteins 0.000 description 1
• 101100489887 Arabidopsis thaliana ABA2 gene Proteins 0.000 description 1
• 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
• 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
• 102100038779 Arfaptin-2 Human genes 0.000 description 1
• 101710107588 Arfaptin-2 Proteins 0.000 description 1
• 241000370685 Arge Species 0.000 description 1
• 102000004452 Arginase Human genes 0.000 description 1
• 108700024123 Arginases Proteins 0.000 description 1
• 108010014885 Arginine-tRNA ligase Proteins 0.000 description 1
• 102100036131 Arginine-tRNA ligase, cytoplasmic Human genes 0.000 description 1
• 206010003497 Asphyxia Diseases 0.000 description 1
• 208000034048 Asymptomatic disease Diseases 0.000 description 1
• 206010003591 Ataxia Diseases 0.000 description 1
• 101150009532 Azgp1 gene Proteins 0.000 description 1
• 102100035647 BRISC and BRCA1-A complex member 1 Human genes 0.000 description 1
• 102100035652 BRISC and BRCA1-A complex member 2 Human genes 0.000 description 1
• 101710086174 BRISC and BRCA1-A complex member 2 Proteins 0.000 description 1
• 102100032435 BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 Human genes 0.000 description 1
• 108700003860 Bacterial Genes Proteins 0.000 description 1
• 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
• 206010056375 Bile duct obstruction Diseases 0.000 description 1
• 102100028741 BolA-like protein 1 Human genes 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 108091005539 Brain-specific angiogenesis inhibitors Proteins 0.000 description 1
• 206010006298 Breast pain Diseases 0.000 description 1
• 206010006482 Bronchospasm Diseases 0.000 description 1
• YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
• 102100034798 CCAAT/enhancer-binding protein beta Human genes 0.000 description 1
• 101710134031 CCAAT/enhancer-binding protein beta Proteins 0.000 description 1
• 101150012716 CDK1 gene Proteins 0.000 description 1
• 101150060249 CHRM3 gene Proteins 0.000 description 1
• 102000004298 CX3C Chemokine Receptor 1 Human genes 0.000 description 1
• 206010006895 Cachexia Diseases 0.000 description 1
• 241000244202 Caenorhabditis Species 0.000 description 1
• 101100478890 Caenorhabditis elegans smo-1 gene Proteins 0.000 description 1
• 102000056906 Calcitonin Receptor-Like Human genes 0.000 description 1
• 101710118454 Calcitonin gene-related peptide type 1 receptor Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
• 101150058073 Calm3 gene Proteins 0.000 description 1
• 102100035023 Carboxypeptidase B2 Human genes 0.000 description 1
• 102000005367 Carboxypeptidases Human genes 0.000 description 1
• 108010006303 Carboxypeptidases Proteins 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 1
• 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 1
• 102000003952 Caspase 3 Human genes 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 101000894568 Catharanthus roseus Catharanthine synthase Proteins 0.000 description 1
• 108090000617 Cathepsin G Proteins 0.000 description 1
• 102000004173 Cathepsin G Human genes 0.000 description 1
• 102400001321 Cathepsin L Human genes 0.000 description 1
• 108090000624 Cathepsin L Proteins 0.000 description 1
• 108010075016 Ceruloplasmin Proteins 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 241000050051 Chelone glabra Species 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 108010009685 Cholinergic Receptors Proteins 0.000 description 1
• 208000031404 Chromosome Aberrations Diseases 0.000 description 1
• 102100035371 Chymotrypsin-like elastase family member 1 Human genes 0.000 description 1
• 101710138848 Chymotrypsin-like elastase family member 1 Proteins 0.000 description 1
• 102000005221 Cleavage Stimulation Factor Human genes 0.000 description 1
• 108010081236 Cleavage Stimulation Factor Proteins 0.000 description 1
• 208000006561 Cluster Headache Diseases 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 108700022408 Coatomer Proteins 0.000 description 1
• 102000057710 Coatomer Human genes 0.000 description 1
• 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
• 102100023659 Coiled-coil domain-containing protein 120 Human genes 0.000 description 1
• 241000723375 Colchicum Species 0.000 description 1
• 102000010091 Cold shock domains Human genes 0.000 description 1
• 108050001774 Cold shock domains Proteins 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010028773 Complement C5 Proteins 0.000 description 1
• 102100031506 Complement C5 Human genes 0.000 description 1
• 102100034528 Core histone macro-H2A.1 Human genes 0.000 description 1
• 101710184999 Core histone macro-H2A.1 Proteins 0.000 description 1
• 208000028006 Corneal injury Diseases 0.000 description 1
• 206010011509 Crystalluria Diseases 0.000 description 1
• BQOHYSXSASDCEA-KEOHHSTQSA-N Cyclic ADP-Ribose Chemical compound C([C@@H]1[C@H]([C@H]([C@@H](O1)N1C=2N=CN3C(C=2N=C1)=N)O)O)OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H]3O1 BQOHYSXSASDCEA-KEOHHSTQSA-N 0.000 description 1
• 101150037071 Cyp1b1 gene Proteins 0.000 description 1
• YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 description 1
• 102100034976 Cystathionine beta-synthase Human genes 0.000 description 1
• 108010073644 Cystathionine beta-synthase Proteins 0.000 description 1
• 102000012192 Cystatin C Human genes 0.000 description 1
• 108010061642 Cystatin C Proteins 0.000 description 1
• 102000005927 Cysteine Proteases Human genes 0.000 description 1
• 108010005843 Cysteine Proteases Proteins 0.000 description 1
• 102100023419 Cystic fibrosis transmembrane conductance regulator Human genes 0.000 description 1
• 108010020076 Cytochrome P-450 CYP2B1 Proteins 0.000 description 1
• 102100039455 Cytochrome b-c1 complex subunit 6, mitochondrial Human genes 0.000 description 1
• 101710147953 Cytochrome b-c1 complex subunit 7 Proteins 0.000 description 1
• 102100027896 Cytochrome b-c1 complex subunit 7 Human genes 0.000 description 1
• 101710147952 Cytochrome b-c1 complex subunit 9 Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• 108020005124 DNA Adducts Proteins 0.000 description 1
• 238000000018 DNA microarray Methods 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 231100001074 DNA strand break Toxicity 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 101710096438 DNA-binding protein Proteins 0.000 description 1
• 206010011906 Death Diseases 0.000 description 1
• RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
• 102100037922 Disco-interacting protein 2 homolog A Human genes 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 108010042091 Dodecenoyl-CoA Isomerase Proteins 0.000 description 1
• 102000004334 Dodecenoyl-CoA Isomerase Human genes 0.000 description 1
• 101100544384 Drosophila melanogaster Yippee gene Proteins 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 101150114701 EPHX1 gene Proteins 0.000 description 1
• 101150105042 EPS8 gene Proteins 0.000 description 1
• 101710099240 Elastase-1 Proteins 0.000 description 1
• 108010024882 Electron Transport Complex III Proteins 0.000 description 1
• 102000015782 Electron Transport Complex III Human genes 0.000 description 1
• 102000012737 Electron-Transferring Flavoproteins Human genes 0.000 description 1
• 108010079426 Electron-Transferring Flavoproteins Proteins 0.000 description 1
• 208000005189 Embolism Diseases 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 108090000860 Endopeptidase Clp Proteins 0.000 description 1
• 208000037487 Endotoxemia Diseases 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 102000005486 Epoxide hydrolase Human genes 0.000 description 1
• 108020002908 Epoxide hydrolase Proteins 0.000 description 1
• 206010015150 Erythema Diseases 0.000 description 1
• 108010056472 Eukaryotic Initiation Factor-4A Proteins 0.000 description 1
• 102100039466 Eukaryotic translation initiation factor 5B Human genes 0.000 description 1
• 108010002700 Exoribonucleases Proteins 0.000 description 1
• 102000004678 Exoribonucleases Human genes 0.000 description 1
• 102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
• 102100039111 FAD-linked sulfhydryl oxidase ALR Human genes 0.000 description 1
• 101710188810 FAD-linked sulfhydryl oxidase ALR Proteins 0.000 description 1
• 101150064712 FNTA gene Proteins 0.000 description 1
• 101150088876 Fabp1 gene Proteins 0.000 description 1
• 108010074864 Factor XI Proteins 0.000 description 1
• 208000023699 Familial male-limited precocious puberty Diseases 0.000 description 1
• 108010007508 Farnesyltranstransferase Proteins 0.000 description 1
• 102000007317 Farnesyltranstransferase Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 102100026561 Filamin-A Human genes 0.000 description 1
• 101710091743 Filamin-A Proteins 0.000 description 1
• 108090000331 Firefly luciferases Proteins 0.000 description 1
• 244000182067 Fraxinus ornus Species 0.000 description 1
• 102000001534 GDP dissociation inhibitor Human genes 0.000 description 1
• 101150054976 GSTT2 gene Proteins 0.000 description 1
• 101150033270 Gadd45a gene Proteins 0.000 description 1
• 101000798427 Gallus gallus Basigin Proteins 0.000 description 1
• 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
• 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
• 101150112014 Gapdh gene Proteins 0.000 description 1
• 101710132438 Gelation factor Proteins 0.000 description 1
• 102100033299 Glia-derived nexin Human genes 0.000 description 1
• PABVKUJVLNMOJP-WHFBIAKZSA-N Glu-Cys Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(O)=O PABVKUJVLNMOJP-WHFBIAKZSA-N 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 208000002705 Glucose Intolerance Diseases 0.000 description 1
• 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
• 102000000340 Glucosyltransferases Human genes 0.000 description 1
• 108010055629 Glucosyltransferases Proteins 0.000 description 1
• 102000018899 Glutamate Receptors Human genes 0.000 description 1
• 108010027915 Glutamate Receptors Proteins 0.000 description 1
• 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
• 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
• 102000017722 Glutamine amidotransferases Human genes 0.000 description 1
• 108050005901 Glutamine amidotransferases Proteins 0.000 description 1
• 101710170157 Glutathione hydrolase Proteins 0.000 description 1
• 102000006587 Glutathione peroxidase Human genes 0.000 description 1
• 108700016172 Glutathione peroxidases Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102100036589 Glycine-tRNA ligase Human genes 0.000 description 1
• 102000051366 Glycosyltransferases Human genes 0.000 description 1
• 108700023372 Glycosyltransferases Proteins 0.000 description 1
• 102000019220 Glycyl-tRNA synthetases Human genes 0.000 description 1
• 206010018634 Gouty Arthritis Diseases 0.000 description 1
• 208000034308 Grand mal convulsion Diseases 0.000 description 1
• 101150103102 Grin3b gene Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 108010070742 Guanidinoacetate N-Methyltransferase Proteins 0.000 description 1
• 102000005756 Guanidinoacetate N-methyltransferase Human genes 0.000 description 1
• 108010092964 Guanine Nucleotide Dissociation Inhibitors Proteins 0.000 description 1
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
• XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
• 101150044653 HMOX1 gene Proteins 0.000 description 1
• 101150003775 HNF1A gene Proteins 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010054147 Hemoglobins Proteins 0.000 description 1
• 102000001554 Hemoglobins Human genes 0.000 description 1
• 206010019629 Hepatic adenoma Diseases 0.000 description 1
• 102000019267 Hepatic lipases Human genes 0.000 description 1
• 108050006747 Hepatic lipases Proteins 0.000 description 1
• 206010019708 Hepatic steatosis Diseases 0.000 description 1
• 102000009824 Hepatocyte Nuclear Factor 1-alpha Human genes 0.000 description 1
• 208000002972 Hepatolenticular Degeneration Diseases 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 102100030338 Hexokinase-1 Human genes 0.000 description 1
• 101710198391 Hexokinase-1 Proteins 0.000 description 1
• 102100029242 Hexokinase-2 Human genes 0.000 description 1
• 101710198385 Hexokinase-2 Proteins 0.000 description 1
• 102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 1
• 108700006308 Histidine ammonia-lyases Proteins 0.000 description 1
• 101000851185 Holotrichia diomphalia Epidermal growth factor-like protein Proteins 0.000 description 1
• 101001135226 Homo sapiens 26S proteasome non-ATPase regulatory subunit 5 Proteins 0.000 description 1
• 101001136717 Homo sapiens 26S proteasome non-ATPase regulatory subunit 8 Proteins 0.000 description 1
• 101000733904 Homo sapiens 39S ribosomal protein L49, mitochondrial Proteins 0.000 description 1
• 101000679249 Homo sapiens 40S ribosomal protein S3a Proteins 0.000 description 1
• 101000822895 Homo sapiens 5-hydroxytryptamine receptor 1A Proteins 0.000 description 1
• 101000964568 Homo sapiens AN1-type zinc finger protein 3 Proteins 0.000 description 1
• 101000986637 Homo sapiens ATP-binding cassette sub-family C member 2 Proteins 0.000 description 1
• 101000902038 Homo sapiens ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Proteins 0.000 description 1
• 101001041697 Homo sapiens ATP-dependent RNA helicase DDX1 Proteins 0.000 description 1
• 101000876352 Homo sapiens Alpha-endosulfine Proteins 0.000 description 1
• 101000755758 Homo sapiens Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 Proteins 0.000 description 1
• 101000874547 Homo sapiens BRISC and BRCA1-A complex member 1 Proteins 0.000 description 1
• 101000798415 Homo sapiens BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 Proteins 0.000 description 1
• 101000695294 Homo sapiens BolA-like protein 1 Proteins 0.000 description 1
• 101000746022 Homo sapiens CX3C chemokine receptor 1 Proteins 0.000 description 1
• 101000946518 Homo sapiens Carboxypeptidase B2 Proteins 0.000 description 1
• 101000978260 Homo sapiens Coiled-coil domain-containing protein 120 Proteins 0.000 description 1
• 101000907783 Homo sapiens Cystic fibrosis transmembrane conductance regulator Proteins 0.000 description 1
• 101000805876 Homo sapiens Disco-interacting protein 2 homolog A Proteins 0.000 description 1
• 101001036496 Homo sapiens Eukaryotic translation initiation factor 5B Proteins 0.000 description 1
• 101000836222 Homo sapiens Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 1
• 101000892677 Homo sapiens Fermitin family homolog 2 Proteins 0.000 description 1
• 101001060280 Homo sapiens Fibroblast growth factor 3 Proteins 0.000 description 1
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
• 101000997803 Homo sapiens Glia-derived nexin Proteins 0.000 description 1
• 101000777670 Homo sapiens Hsp90 co-chaperone Cdc37 Proteins 0.000 description 1
• 101000966742 Homo sapiens Leucine-rich PPR motif-containing protein, mitochondrial Proteins 0.000 description 1
• 101001044093 Homo sapiens Lipopolysaccharide-induced tumor necrosis factor-alpha factor Proteins 0.000 description 1
• 101000677545 Homo sapiens Long-chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 1
• 101000658867 Homo sapiens Lysine-tRNA ligase Proteins 0.000 description 1
• 101001116774 Homo sapiens Methionine-R-sulfoxide reductase B2, mitochondrial Proteins 0.000 description 1
• 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 1
• 101000577033 Homo sapiens Monocarboxylate transporter 7 Proteins 0.000 description 1
• 101001013159 Homo sapiens Myeloid leukemia factor 2 Proteins 0.000 description 1
• 101000982003 Homo sapiens Myopalladin Proteins 0.000 description 1
• 101000636705 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial Proteins 0.000 description 1
• 101100460659 Homo sapiens NOP16 gene Proteins 0.000 description 1
• 101000634768 Homo sapiens Nucleolar protein 16 Proteins 0.000 description 1
• 101001113717 Homo sapiens Phenazine biosynthesis-like domain-containing protein Proteins 0.000 description 1
• 101000610204 Homo sapiens Poly(A) polymerase alpha Proteins 0.000 description 1
• 101001083769 Homo sapiens Probable helicase with zinc finger domain Proteins 0.000 description 1
• 101001056111 Homo sapiens Protein max Proteins 0.000 description 1
• 101000654448 Homo sapiens Protein transport protein Sec16A Proteins 0.000 description 1
• 101000580720 Homo sapiens RNA-binding protein 25 Proteins 0.000 description 1
• 101001099888 Homo sapiens Ras-related protein Rab-3D Proteins 0.000 description 1
• 101000984584 Homo sapiens Ribosome biogenesis protein BOP1 Proteins 0.000 description 1
• 101000631899 Homo sapiens Ribosome maturation protein SBDS Proteins 0.000 description 1
• 101100203078 Homo sapiens SF3B6 gene Proteins 0.000 description 1
• 101000835860 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 Proteins 0.000 description 1
• 101000654335 Homo sapiens Secernin-1 Proteins 0.000 description 1
• 101000642661 Homo sapiens Serine-threonine kinase receptor-associated protein Proteins 0.000 description 1
• 101000829212 Homo sapiens Serine/arginine repetitive matrix protein 2 Proteins 0.000 description 1
• 101000639972 Homo sapiens Sodium-dependent dopamine transporter Proteins 0.000 description 1
• 101000664921 Homo sapiens Sorting nexin-4 Proteins 0.000 description 1
• 101000665025 Homo sapiens Sorting nexin-6 Proteins 0.000 description 1
• 101000616188 Homo sapiens Splicing factor 3B subunit 6 Proteins 0.000 description 1
• 101000685323 Homo sapiens Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Proteins 0.000 description 1
• 101000648553 Homo sapiens Sushi domain-containing protein 6 Proteins 0.000 description 1
• 101000653538 Homo sapiens Transcription factor 25 Proteins 0.000 description 1
• 101000837841 Homo sapiens Transcription factor EB Proteins 0.000 description 1
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
• 101000863873 Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 description 1
• 101100032613 Homo sapiens UQCR10 gene Proteins 0.000 description 1
• 101000808784 Homo sapiens Ubiquitin-conjugating enzyme E2 R1 Proteins 0.000 description 1
• 101000671638 Homo sapiens Vesicle transport protein USE1 Proteins 0.000 description 1
• 101000667295 Homo sapiens WASH complex subunit 3 Proteins 0.000 description 1
• 101000823782 Homo sapiens Y-box-binding protein 3 Proteins 0.000 description 1
• 101000818517 Homo sapiens Zinc-alpha-2-glycoprotein Proteins 0.000 description 1
• 101000988424 Homo sapiens cAMP-specific 3',5'-cyclic phosphodiesterase 4B Proteins 0.000 description 1
• 101000667264 Homo sapiens von Willebrand factor A domain-containing protein 8 Proteins 0.000 description 1
• 208000033830 Hot Flashes Diseases 0.000 description 1
• 206010060800 Hot flush Diseases 0.000 description 1
• 102100031568 Hsp90 co-chaperone Cdc37 Human genes 0.000 description 1
• 101150045775 Htr3a gene Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 206010020575 Hyperammonaemia Diseases 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 208000013016 Hypoglycemia Diseases 0.000 description 1
• 208000001953 Hypotension Diseases 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
• 108010042653 IgA receptor Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102100036489 Immunoglobulin superfamily member 8 Human genes 0.000 description 1
• 101710181535 Immunoglobulin superfamily member 8 Proteins 0.000 description 1
• 206010052341 Impaired insulin secretion Diseases 0.000 description 1
• 102100028799 Inner nuclear membrane protein Man1 Human genes 0.000 description 1
• 101710087161 Inner nuclear membrane protein Man1 Proteins 0.000 description 1
• 102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 1
• 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 101710180095 Inositol-1-monophosphatase Proteins 0.000 description 1
• 101710081113 Inositol-1-monophosphatase SuhB Proteins 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102100034343 Integrase Human genes 0.000 description 1
• 108010061833 Integrases Proteins 0.000 description 1
• 101150064984 Irf1 gene Proteins 0.000 description 1
• 108010013792 Isovaleryl-CoA Dehydrogenase Proteins 0.000 description 1
• 102100025392 Isovaleryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
• 108010030685 KDEL receptor Proteins 0.000 description 1
• 108060005987 Kallikrein Proteins 0.000 description 1
• 102000001399 Kallikrein Human genes 0.000 description 1
• 108010062228 Karyopherins Proteins 0.000 description 1
• 102000011781 Karyopherins Human genes 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ILRYLPWNYFXEMH-WHFBIAKZSA-N L-cystathionine Chemical compound [O-]C(=O)[C@@H]([NH3+])CCSC[C@H]([NH3+])C([O-])=O ILRYLPWNYFXEMH-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• 102100023981 Lamina-associated polypeptide 2, isoform alpha Human genes 0.000 description 1
• 101710163560 Lamina-associated polypeptide 2, isoform alpha Proteins 0.000 description 1
• 101710189385 Lamina-associated polypeptide 2, isoforms beta/gamma Proteins 0.000 description 1
• 101710173438 Late L2 mu core protein Proteins 0.000 description 1
• 206010024264 Lethargy Diseases 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100040274 Leucine-zipper-like transcriptional regulator 1 Human genes 0.000 description 1
• 101710138656 Leucine-zipper-like transcriptional regulator 1 Proteins 0.000 description 1
• 102000004882 Lipase Human genes 0.000 description 1
• 108090001060 Lipase Proteins 0.000 description 1
• 239000004367 Lipase Substances 0.000 description 1
• 102100021607 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human genes 0.000 description 1
• 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
• 102100022119 Lipoprotein lipase Human genes 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102100021644 Long-chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
• 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
• 108091054455 MAP kinase family Proteins 0.000 description 1
• 102000043136 MAP kinase family Human genes 0.000 description 1
• 101150039798 MYC gene Proteins 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 206010026749 Mania Diseases 0.000 description 1
• 208000001940 Massive Hepatic Necrosis Diseases 0.000 description 1
• 208000006662 Mastodynia Diseases 0.000 description 1
• WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 1
• 101150023310 Mcfd2 gene Proteins 0.000 description 1
• 108030000845 Medium-chain acyl-CoA dehydrogenases Proteins 0.000 description 1
• 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
• 206010027304 Menopausal symptoms Diseases 0.000 description 1
• 102000005741 Metalloproteases Human genes 0.000 description 1
• 108010006035 Metalloproteases Proteins 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 102100024862 Methionine-R-sulfoxide reductase B2, mitochondrial Human genes 0.000 description 1
• 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 1
• 102000029749 Microtubule Human genes 0.000 description 1
• 108091022875 Microtubule Proteins 0.000 description 1
• 102000010909 Monoamine Oxidase Human genes 0.000 description 1
• 108010062431 Monoamine oxidase Proteins 0.000 description 1
• 102100025311 Monocarboxylate transporter 7 Human genes 0.000 description 1
• 102000017298 Monocarboxylate transporters Human genes 0.000 description 1
• 108050005244 Monocarboxylate transporters Proteins 0.000 description 1
• 101710151833 Movement protein TGBp3 Proteins 0.000 description 1
• 102100034263 Mucin-2 Human genes 0.000 description 1
• 108010008705 Mucin-2 Proteins 0.000 description 1
• 108010063954 Mucins Proteins 0.000 description 1
• 102000015728 Mucins Human genes 0.000 description 1
• 208000034486 Multi-organ failure Diseases 0.000 description 1
• 101100400864 Mus musculus Abcb1a gene Proteins 0.000 description 1
• 101100490687 Mus musculus Agtr1a gene Proteins 0.000 description 1
• 101000974920 Mus musculus Cyclic AMP-dependent transcription factor ATF-3 Proteins 0.000 description 1
• 101100061205 Mus musculus Cyp2a5 gene Proteins 0.000 description 1
• 101001013189 Mus musculus Myeloid leukemia factor 2 Proteins 0.000 description 1
• 101100309386 Mus musculus Slc35a2 gene Proteins 0.000 description 1
• 101000707568 Mus musculus Splicing factor 3A subunit 3 Proteins 0.000 description 1
• 101100377273 Mus musculus Zfand3 gene Proteins 0.000 description 1
• 102000047918 Myelin Basic Human genes 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
• 102100029687 Myeloid leukemia factor 2 Human genes 0.000 description 1
• 102100026786 Myopalladin Human genes 0.000 description 1
• 102000005604 Myosin Heavy Chains Human genes 0.000 description 1
• 108010084498 Myosin Heavy Chains Proteins 0.000 description 1
• IWVSYNGKNZFSSA-PTDVUUCPSA-N N(omega)-(ADP-D-ribosyl)-L-arginine Chemical compound O[C@H]1[C@@H](O)[C@@H](NC(=N)NCCC[C@H](N)C(O)=O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=NC=NC(N)=C3N=C2)O1 IWVSYNGKNZFSSA-PTDVUUCPSA-N 0.000 description 1
• CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
• BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
• 108020000284 NAD(P)H dehydrogenase (quinone) Proteins 0.000 description 1
• 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 1
• 102100031919 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial Human genes 0.000 description 1
• QBUXOPFBZFYVHP-UHFFFAOYSA-N NC1=C(N=CN1)C(=O)N.NC1=C(N=CN1)C(=O)N Chemical compound NC1=C(N=CN1)C(=O)N.NC1=C(N=CN1)C(=O)N QBUXOPFBZFYVHP-UHFFFAOYSA-N 0.000 description 1
• 108010057466 NF-kappa B Proteins 0.000 description 1
• 102000003945 NF-kappa B Human genes 0.000 description 1
• 101150016983 NFIA gene Proteins 0.000 description 1
• 108010084810 Neurotransmitter Transport Proteins Proteins 0.000 description 1
• 102000005665 Neurotransmitter Transport Proteins Human genes 0.000 description 1
• IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
• 206010067482 No adverse event Diseases 0.000 description 1
• 101710188688 Non-structural protein 7a Proteins 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 101710173384 Nus factor SuhB Proteins 0.000 description 1
• 206010030113 Oedema Diseases 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 108010061952 Orosomucoid Proteins 0.000 description 1
• 102000012404 Orosomucoid Human genes 0.000 description 1
• 208000001164 Osteoporotic Fractures Diseases 0.000 description 1
• 102000004020 Oxygenases Human genes 0.000 description 1
• 108090000417 Oxygenases Proteins 0.000 description 1
• 102000003697 P-type ATPases Human genes 0.000 description 1
• 108090000069 P-type ATPases Proteins 0.000 description 1
• 101150005879 PKM gene Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 101000708299 Paracoccus denitrificans Uncharacterized 14.7 kDa protein in nqo3 5'region Proteins 0.000 description 1
• 206010033864 Paranoia Diseases 0.000 description 1
• 208000027099 Paranoid disease Diseases 0.000 description 1
• 102000003982 Parathyroid hormone Human genes 0.000 description 1
• 108090000445 Parathyroid hormone Proteins 0.000 description 1
• 208000027089 Parkinsonian disease Diseases 0.000 description 1
• 206010034010 Parkinsonism Diseases 0.000 description 1
• 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
• 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 102100039087 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Human genes 0.000 description 1
• 102100026798 Peroxisomal acyl-coenzyme A oxidase 1 Human genes 0.000 description 1
• 102100038883 Peroxisomal biogenesis factor 19 Human genes 0.000 description 1
• 101710142874 Peroxisomal biogenesis factor 19 Proteins 0.000 description 1
• 102100023743 Phenazine biosynthesis-like domain-containing protein Human genes 0.000 description 1
• YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
• 102100024634 Phosphatidylserine lipase ABHD16A Human genes 0.000 description 1
• 101710193683 Phosphatidylserine lipase ABHD16A Proteins 0.000 description 1
• 102100039298 Phosphatidylserine synthase 1 Human genes 0.000 description 1
• 101710116266 Phosphatidylserine synthase 1 Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 108090000113 Plasma Kallikrein Proteins 0.000 description 1
• 102100034869 Plasma kallikrein Human genes 0.000 description 1
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
• 208000005374 Poisoning Diseases 0.000 description 1
• 101710176113 Poliovirus receptor homolog Proteins 0.000 description 1
• 102100040155 Poly(A) polymerase alpha Human genes 0.000 description 1
• 101710176386 Poly(A) polymerase alpha Proteins 0.000 description 1
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
• 101710118038 Probable actin-related protein 2/3 complex subunit 2 Proteins 0.000 description 1
• 102100031018 Probable helicase with zinc finger domain Human genes 0.000 description 1
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 108030004374 Proline-tRNA ligases Proteins 0.000 description 1
• 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
• 108030003866 Prostaglandin-D synthases Proteins 0.000 description 1
• 102100033279 Prostaglandin-H2 D-isomerase Human genes 0.000 description 1
• 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
• 101800004937 Protein C Proteins 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 108010058956 Protein Phosphatase 2 Proteins 0.000 description 1
• 102000006478 Protein Phosphatase 2 Human genes 0.000 description 1
• 102100023087 Protein S100-A4 Human genes 0.000 description 1
• 108010001267 Protein Subunits Proteins 0.000 description 1
• 102000002067 Protein Subunits Human genes 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• 102100026558 Protein max Human genes 0.000 description 1
• 101710151004 Protein transport protein SEC61 Proteins 0.000 description 1
• 102100031479 Protein transport protein Sec16A Human genes 0.000 description 1
• 102100023146 Protein transport protein Sec24B Human genes 0.000 description 1
• 101710198501 Protein transport protein Sec24B Proteins 0.000 description 1
• 102100036308 Protein transport protein Sec61 subunit beta Human genes 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 108010094028 Prothrombin Proteins 0.000 description 1
• 102000015176 Proton-Translocating ATPases Human genes 0.000 description 1
• 108010039518 Proton-Translocating ATPases Proteins 0.000 description 1
• 101710113809 Putative Nus factor SuhB Proteins 0.000 description 1
• 102000009609 Pyrophosphatases Human genes 0.000 description 1
• 108010009413 Pyrophosphatases Proteins 0.000 description 1
• 108010010469 Qa-SNARE Proteins Proteins 0.000 description 1
• 108010005730 R-SNARE Proteins Proteins 0.000 description 1
• 108010009460 RNA Polymerase II Proteins 0.000 description 1
• 102000009572 RNA Polymerase II Human genes 0.000 description 1
• 108020005093 RNA Precursors Proteins 0.000 description 1
• 108090001087 RNA ligase (ATP) Proteins 0.000 description 1
• 239000013614 RNA sample Substances 0.000 description 1
• 102100027478 RNA-binding protein 25 Human genes 0.000 description 1
• 238000011530 RNeasy Mini Kit Methods 0.000 description 1
• 102100022122 Ras-related C3 botulinum toxin substrate 1 Human genes 0.000 description 1
• 102100038474 Ras-related protein Rab-3D Human genes 0.000 description 1
• 101710116841 Ras-related protein Rap-1A Proteins 0.000 description 1
• 101100490691 Rattus norvegicus Agtr1b gene Proteins 0.000 description 1
• 101100115246 Rattus norvegicus Cx3cr1 gene Proteins 0.000 description 1
• 101000912221 Rattus norvegicus Cystatin-B Proteins 0.000 description 1
• 101000886292 Rattus norvegicus Death-associated protein 1 Proteins 0.000 description 1
• 108091005682 Receptor kinases Proteins 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 206010061481 Renal injury Diseases 0.000 description 1
• 206010038491 Renal papillary necrosis Diseases 0.000 description 1
• 238000012952 Resampling Methods 0.000 description 1
• 206010039020 Rhabdomyolysis Diseases 0.000 description 1
• 101000823680 Rhodospirillum rubrum Uncharacterized protein in ATPase CF(0) subunits 3'region Proteins 0.000 description 1
• 102100033790 Ribonuclease P protein subunit p38 Human genes 0.000 description 1
• 101710187980 Ribonuclease P protein subunit p38 Proteins 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 102000004282 Ribosomal protein S9 Human genes 0.000 description 1
• 108090000878 Ribosomal protein S9 Proteins 0.000 description 1
• 102100027055 Ribosome biogenesis protein BOP1 Human genes 0.000 description 1
• 102100028750 Ribosome maturation protein SBDS Human genes 0.000 description 1
• 101150089497 RpS29 gene Proteins 0.000 description 1
• 230000018199 S phase Effects 0.000 description 1
• 108010085149 S100 Calcium-Binding Protein A4 Proteins 0.000 description 1
• 101150002135 SDC1 gene Proteins 0.000 description 1
• 101150012612 SELENOW gene Proteins 0.000 description 1
• 101150036449 SIRPA gene Proteins 0.000 description 1
• 101150102102 SMT3 gene Proteins 0.000 description 1
• 102000000583 SNARE Proteins Human genes 0.000 description 1
• 108010041948 SNARE Proteins Proteins 0.000 description 1
• 101150096255 SUMO1 gene Proteins 0.000 description 1
• 102100025746 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 Human genes 0.000 description 1
• 101100501251 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ELO3 gene Proteins 0.000 description 1
• YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
• 206010039424 Salivary hypersecretion Diseases 0.000 description 1
• 102400000827 Saposin-D Human genes 0.000 description 1
• 101800001700 Saposin-D Proteins 0.000 description 1
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
• 101100408688 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pmt3 gene Proteins 0.000 description 1
• 208000034189 Sclerosis Diseases 0.000 description 1
• 102100031312 Secernin-1 Human genes 0.000 description 1
• 108091058545 Secretory proteins Proteins 0.000 description 1
• 102000040739 Secretory proteins Human genes 0.000 description 1
• 102000008114 Selenoproteins Human genes 0.000 description 1
• 108010074686 Selenoproteins Proteins 0.000 description 1
• 206010040047 Sepsis Diseases 0.000 description 1
• 206010040070 Septic Shock Diseases 0.000 description 1
• 102100035934 Serine-threonine kinase receptor-associated protein Human genes 0.000 description 1
• 102100023657 Serine/arginine repetitive matrix protein 2 Human genes 0.000 description 1
• 101150040974 Set gene Proteins 0.000 description 1
• 108030000856 Short-chain acyl-CoA dehydrogenases Proteins 0.000 description 1
• 102100027318 Signal recognition particle subunit SRP68 Human genes 0.000 description 1
• 101710132566 Signal recognition particle subunit srp68 Proteins 0.000 description 1
• BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
• 102000000244 Sm-like protein LSm5 Human genes 0.000 description 1
• 108050008689 Sm-like protein LSm5 Proteins 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 102100033928 Sodium-dependent dopamine transporter Human genes 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 108010068542 Somatotropin Receptors Proteins 0.000 description 1
• 206010041349 Somnolence Diseases 0.000 description 1
• 102100038650 Sorting nexin-4 Human genes 0.000 description 1
• 101710103886 Sorting nexin-4 Proteins 0.000 description 1
• 108050006109 Sorting nexin-6 Proteins 0.000 description 1
• 102000017168 Sterol 14-Demethylase Human genes 0.000 description 1
• 108010013803 Sterol 14-Demethylase Proteins 0.000 description 1
• 108010074436 Sterol Regulatory Element Binding Protein 1 Proteins 0.000 description 1
• 102100026839 Sterol regulatory element-binding protein 1 Human genes 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 102100023155 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial Human genes 0.000 description 1
• 102000005566 Succinate-Semialdehyde Dehydrogenase Human genes 0.000 description 1
• 108010084086 Succinate-Semialdehyde Dehydrogenase Proteins 0.000 description 1
• 101710083456 Sulfotransferase 1E1 Proteins 0.000 description 1
• 102100029862 Sulfotransferase 1E1 Human genes 0.000 description 1
• 102000004896 Sulfotransferases Human genes 0.000 description 1
• 108090001033 Sulfotransferases Proteins 0.000 description 1
• OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 101710137422 Suppressor of cytokine signaling 2 Proteins 0.000 description 1
• 102100024784 Suppressor of cytokine signaling 2 Human genes 0.000 description 1
• 102100028858 Sushi domain-containing protein 6 Human genes 0.000 description 1
• 102000002215 Synaptobrevin Human genes 0.000 description 1
• 102000050389 Syntaxin Human genes 0.000 description 1
• 102000006467 TATA-Box Binding Protein Human genes 0.000 description 1
• 108010044281 TATA-Box Binding Protein Proteins 0.000 description 1
• 101150052863 THY1 gene Proteins 0.000 description 1
• 101150081494 TMPO gene Proteins 0.000 description 1
• 101150098159 TSHR gene Proteins 0.000 description 1
• 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 1
• 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 1
• 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 1
• 102000002932 Thiolase Human genes 0.000 description 1
• 108060008225 Thiolase Proteins 0.000 description 1
• 208000001435 Thromboembolism Diseases 0.000 description 1
• 108010046722 Thrombospondin 1 Proteins 0.000 description 1
• 102100036034 Thrombospondin-1 Human genes 0.000 description 1
• 239000000898 Thymopoietin Substances 0.000 description 1
• 108090000253 Thyrotropin Receptors Proteins 0.000 description 1
• 102100029337 Thyrotropin receptor Human genes 0.000 description 1
• 102100030628 Transcription factor 25 Human genes 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 108010033576 Transferrin Receptors Proteins 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 102100026229 Translocon-associated protein subunit beta Human genes 0.000 description 1
• 101710141448 Translocon-associated protein subunit beta Proteins 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 108010030743 Tropomyosin Proteins 0.000 description 1
• 102000005937 Tropomyosin Human genes 0.000 description 1
• 102100033632 Tropomyosin alpha-1 chain Human genes 0.000 description 1
• 101710128188 Tropomyosin alpha-1 chain Proteins 0.000 description 1
• 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 description 1
• 102000057288 Tryptophan 2,3-dioxygenases Human genes 0.000 description 1
• 108700016206 Tryptophan-tRNA ligases Proteins 0.000 description 1
• 101150025935 Tspo gene Proteins 0.000 description 1
• 102100031638 Tuberin Human genes 0.000 description 1
• 108050009309 Tuberin Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 206010054094 Tumour necrosis Diseases 0.000 description 1
• 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 description 1
• 101710160880 Type-1A angiotensin II receptor Proteins 0.000 description 1
• 102100021869 Tyrosine aminotransferase Human genes 0.000 description 1
• 108010042606 Tyrosine transaminase Proteins 0.000 description 1
• 108010082433 UDP-glucose-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
• 102000039353 UDP-glycosyltransferase family Human genes 0.000 description 1
• 101710088074 UTP-glucose-1-phosphate uridylyltransferase 2 Proteins 0.000 description 1
• 108700023183 UTP-glucose-1-phosphate uridylyltransferases Proteins 0.000 description 1
• 102100020696 Ubiquitin-conjugating enzyme E2 K Human genes 0.000 description 1
• 101710101311 Ubiquitin-conjugating enzyme E2 R1 Proteins 0.000 description 1
• 101150060067 Uggt1 gene Proteins 0.000 description 1
• 101150115356 Ugt1a1 gene Proteins 0.000 description 1
• 101150064302 Ugt1a2 gene Proteins 0.000 description 1
• 101150068269 Ugt1a6 gene Proteins 0.000 description 1
• LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
• TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
• 208000024780 Urticaria Diseases 0.000 description 1
• NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
• 102100040106 Vesicle transport protein USE1 Human genes 0.000 description 1
• 102000004603 Vesicle-Associated Membrane Protein 1 Human genes 0.000 description 1
• 108010017743 Vesicle-Associated Membrane Protein 1 Proteins 0.000 description 1
• 102000003786 Vesicle-associated membrane protein 2 Human genes 0.000 description 1
• 108090000169 Vesicle-associated membrane protein 2 Proteins 0.000 description 1
• 206010047571 Visual impairment Diseases 0.000 description 1
• 229930003448 Vitamin K Natural products 0.000 description 1
• 240000006365 Vitis vinifera Species 0.000 description 1
• 208000018839 Wilson disease Diseases 0.000 description 1
• 102100022221 Y-box-binding protein 3 Human genes 0.000 description 1
• 101150027038 YWHAH gene Proteins 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• 102100029022 Zinc finger protein 330 Human genes 0.000 description 1
• 101710146922 Zinc finger protein 330 Proteins 0.000 description 1
• 102100021144 Zinc-alpha-2-glycoprotein Human genes 0.000 description 1
• GYBNOAFGEKAZTA-QOLULZROSA-N [(6z,10e,14e)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] dihydrogen phosphate Chemical compound OP(=O)(O)OCCC(C)CC\C=C(\C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C GYBNOAFGEKAZTA-QOLULZROSA-N 0.000 description 1
• 230000003187 abdominal effect Effects 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 208000028311 absence seizure Diseases 0.000 description 1
• 108010063628 acarboxyprothrombin Proteins 0.000 description 1
• GNAMIIWTFJSWTC-LUWBGTNYSA-N acetyl (4S,5R,6R)-5-amino-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate Chemical compound CC(=O)OC(=O)C1(O)C[C@H](O)[C@@H](N)[C@H]([C@H](O)[C@H](O)CO)O1 GNAMIIWTFJSWTC-LUWBGTNYSA-N 0.000 description 1
• 102000034337 acetylcholine receptors Human genes 0.000 description 1
• 206010000496 acne Diseases 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
• 230000010398 acute inflammatory response Effects 0.000 description 1
• 231100000439 acute liver injury Toxicity 0.000 description 1
• 238000011047 acute toxicity test Methods 0.000 description 1
• 230000004658 acute-phase response Effects 0.000 description 1
• 102000005130 adenylosuccinate synthetase Human genes 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 238000012387 aerosolization Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 229930013930 alkaloid Natural products 0.000 description 1
• 230000002152 alkylating effect Effects 0.000 description 1
• 229940087168 alpha tocopherol Drugs 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 108010003977 aminoacylase I Proteins 0.000 description 1
• 229940124277 aminobutyric acid Drugs 0.000 description 1
• 230000037005 anaesthesia Effects 0.000 description 1
• 230000003444 anaesthetic effect Effects 0.000 description 1
• 229940035676 analgesics Drugs 0.000 description 1
• 206010068168 androgenetic alopecia Diseases 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 208000022531 anorexia Diseases 0.000 description 1
• 230000001088 anti-asthma Effects 0.000 description 1
• 230000003556 anti-epileptic effect Effects 0.000 description 1
• 230000003276 anti-hypertensive effect Effects 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 230000002402 anti-lipaemic effect Effects 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
• 239000000924 antiasthmatic agent Substances 0.000 description 1
• 239000001961 anticonvulsive agent Substances 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 239000003080 antimitotic agent Substances 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 230000006851 antioxidant defense Effects 0.000 description 1
• 230000003078 antioxidant effect Effects 0.000 description 1
• 229940125716 antipyretic agent Drugs 0.000 description 1
• 230000036506 anxiety Effects 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• 230000004596 appetite loss Effects 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 229940114079 arachidonic acid Drugs 0.000 description 1
• 235000021342 arachidonic acid Nutrition 0.000 description 1
• 238000013528 artificial neural network Methods 0.000 description 1
• 210000003567 ascitic fluid Anatomy 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 208000029618 autoimmune pulmonary alveolar proteinosis Diseases 0.000 description 1
• 230000002567 autonomic effect Effects 0.000 description 1
• 210000003403 autonomic nervous system Anatomy 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 208000013053 benign Leydig cell tumor Diseases 0.000 description 1
• 102000012012 beta Karyopherins Human genes 0.000 description 1
• 108010075890 beta Karyopherins Proteins 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 229940093761 bile salts Drugs 0.000 description 1
• 208000027119 bilirubin metabolic disease Diseases 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 239000000090 biomarker Substances 0.000 description 1
• 230000033558 biomineral tissue development Effects 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 229940112869 bone morphogenetic protein Drugs 0.000 description 1
• 230000007885 bronchoconstriction Effects 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 230000023852 carbohydrate metabolic process Effects 0.000 description 1
• 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229910002092 carbon dioxide Inorganic materials 0.000 description 1
• 229950005499 carbon tetrachloride Drugs 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 208000037887 cell injury Diseases 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 229940106189 ceramide Drugs 0.000 description 1
• ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
• 210000004720 cerebrum Anatomy 0.000 description 1
• 238000012412 chemical coupling Methods 0.000 description 1
• 229960001701 chloroform Drugs 0.000 description 1
• YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 231100000005 chromosome aberration Toxicity 0.000 description 1
• 231100000132 chronic toxicity testing Toxicity 0.000 description 1
• TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 1
• 229950008441 clofibric acid Drugs 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000035602 clotting Effects 0.000 description 1
• 238000007621 cluster analysis Methods 0.000 description 1
• AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
• ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
• 230000006999 cognitive decline Effects 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 230000001447 compensatory effect Effects 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 208000029078 coronary artery disease Diseases 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000007797 corrosion Effects 0.000 description 1
• 238000005260 corrosion Methods 0.000 description 1
• 230000001054 cortical effect Effects 0.000 description 1
• 229960003624 creatine Drugs 0.000 description 1
• 239000006046 creatine Substances 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 229940089052 depakene Drugs 0.000 description 1
• 239000000645 desinfectant Substances 0.000 description 1
• 230000000368 destabilizing effect Effects 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 150000001991 dicarboxylic acids Chemical class 0.000 description 1
• 210000002451 diencephalon Anatomy 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 125000004212 difluorophenyl group Chemical group 0.000 description 1
• 230000010339 dilation Effects 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 108010057167 dimethylaniline monooxygenase (N-oxide forming) Proteins 0.000 description 1
• 230000008034 disappearance Effects 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 208000002173 dizziness Diseases 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 229940072701 dolobid Drugs 0.000 description 1
• 229960003638 dopamine Drugs 0.000 description 1
• 230000002222 downregulating effect Effects 0.000 description 1
• 238000001647 drug administration Methods 0.000 description 1
• 229940000406 drug candidate Drugs 0.000 description 1
• 229940072185 drug for treatment of tuberculosis Drugs 0.000 description 1
• 230000036267 drug metabolism Effects 0.000 description 1
• 238000003255 drug test Methods 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000001493 electron microscopy Methods 0.000 description 1
• 239000012039 electrophile Substances 0.000 description 1
• 210000004696 endometrium Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000003511 endothelial effect Effects 0.000 description 1
• 231100000821 endpoints of toxicity testing Toxicity 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 231100000321 erythema Toxicity 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 238000009164 estrogen replacement therapy Methods 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• 125000004494 ethyl ester group Chemical group 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000005713 exacerbation Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 238000000556 factor analysis Methods 0.000 description 1
• 230000002550 fecal effect Effects 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• 238000010304 firing Methods 0.000 description 1
• 108700025906 fos Genes Proteins 0.000 description 1
• 235000021588 free fatty acids Nutrition 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 230000008717 functional decline Effects 0.000 description 1
• 230000000855 fungicidal effect Effects 0.000 description 1
• 239000000417 fungicide Substances 0.000 description 1
• 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
• 238000003500 gene array Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 231100000024 genotoxic Toxicity 0.000 description 1
• 230000001738 genotoxic effect Effects 0.000 description 1
• 230000001434 glomerular Effects 0.000 description 1
• 229950010772 glucose-1-phosphate Drugs 0.000 description 1
• 102000005396 glutamine synthetase Human genes 0.000 description 1
• 108020002326 glutamine synthetase Proteins 0.000 description 1
• SYKWLIJQEHRDNH-CKRMAKSASA-N glutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 SYKWLIJQEHRDNH-CKRMAKSASA-N 0.000 description 1
• 244000144993 groups of animals Species 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• BPMFZUMJYQTVII-UHFFFAOYSA-N guanidinoacetic acid Chemical compound NC(=N)NCC(O)=O BPMFZUMJYQTVII-UHFFFAOYSA-N 0.000 description 1
• 201000000079 gynecomastia Diseases 0.000 description 1
• 230000009931 harmful effect Effects 0.000 description 1
• 239000000383 hazardous chemical Substances 0.000 description 1
• 210000002837 heart atrium Anatomy 0.000 description 1
• 208000024798 heartburn Diseases 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 208000006750 hematuria Diseases 0.000 description 1
• 230000002008 hemorrhagic effect Effects 0.000 description 1
• 230000010224 hepatic metabolism Effects 0.000 description 1
• 230000007866 hepatic necrosis Effects 0.000 description 1
• 230000001378 hepatocarcinogenic effect Effects 0.000 description 1
• 230000028974 hepatocyte apoptotic process Effects 0.000 description 1
• 239000004009 herbicide Substances 0.000 description 1
• 238000007417 hierarchical cluster analysis Methods 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229960002474 hydralazine Drugs 0.000 description 1
• ZGCHATBSUIJLRL-UHFFFAOYSA-N hydrazine sulfate Chemical compound NN.OS(O)(=O)=O ZGCHATBSUIJLRL-UHFFFAOYSA-N 0.000 description 1
• 150000002429 hydrazines Chemical class 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
• ZUFVXZVXEJHHBN-UHFFFAOYSA-N hydron;1,2,3,4-tetrahydroacridin-9-amine;chloride Chemical compound [Cl-].C1=CC=C2C([NH3+])=C(CCCC3)C3=NC2=C1 ZUFVXZVXEJHHBN-UHFFFAOYSA-N 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• 208000013403 hyperactivity Diseases 0.000 description 1
• 208000036796 hyperbilirubinemia Diseases 0.000 description 1
• 230000002390 hyperplastic effect Effects 0.000 description 1
• 239000003326 hypnotic agent Substances 0.000 description 1
• 230000002218 hypoglycaemic effect Effects 0.000 description 1
• 230000036543 hypotension Effects 0.000 description 1
• 208000018875 hypoxemia Diseases 0.000 description 1
• 229960001680 ibuprofen Drugs 0.000 description 1
• 238000005286 illumination Methods 0.000 description 1
• 238000010324 immunological assay Methods 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 206010021654 increased appetite Diseases 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 239000003317 industrial substance Substances 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000037456 inflammatory mechanism Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 230000000266 injurious effect Effects 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 201000006334 interstitial nephritis Diseases 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 208000001024 intrahepatic cholestasis Diseases 0.000 description 1
• 230000007872 intrahepatic cholestasis Effects 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 239000002085 irritant Substances 0.000 description 1
• 231100000021 irritant Toxicity 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 229960003350 isoniazid Drugs 0.000 description 1
• QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
• 108700025907 jun Genes Proteins 0.000 description 1
• 206010023365 keratopathy Diseases 0.000 description 1
• 230000003907 kidney function Effects 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 230000006651 lactation Effects 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 108010007628 lamina-associated polypeptide 2 Proteins 0.000 description 1
• 239000010985 leather Substances 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 231100001231 less toxic Toxicity 0.000 description 1
• 150000002617 leukotrienes Chemical class 0.000 description 1
• 210000002332 leydig cell Anatomy 0.000 description 1
• 238000012417 linear regression Methods 0.000 description 1
• 235000019421 lipase Nutrition 0.000 description 1
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 102000004311 liver X receptors Human genes 0.000 description 1
• 108090000865 liver X receptors Proteins 0.000 description 1
• 230000005976 liver dysfunction Effects 0.000 description 1
• 231100000835 liver failure Toxicity 0.000 description 1
• 230000003908 liver function Effects 0.000 description 1
• 238000007449 liver function test Methods 0.000 description 1
• 208000018191 liver inflammation Diseases 0.000 description 1
• 210000002311 liver mitochondria Anatomy 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 208000019017 loss of appetite Diseases 0.000 description 1
• 235000021266 loss of appetite Nutrition 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000000873 masking effect Effects 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 210000003622 mature neutrocyte Anatomy 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000028161 membrane depolarization Effects 0.000 description 1
• 230000037353 metabolic pathway Effects 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• IDBOAVAEGRJRIZ-UHFFFAOYSA-N methylidenehydrazine Chemical compound NN=C IDBOAVAEGRJRIZ-UHFFFAOYSA-N 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 210000002500 microbody Anatomy 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 238000007431 microscopic evaluation Methods 0.000 description 1
• 210000004688 microtubule Anatomy 0.000 description 1
• 210000000110 microvilli Anatomy 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000003607 modifier Substances 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 210000000947 motile cell Anatomy 0.000 description 1
• 230000037023 motor activity Effects 0.000 description 1
• 210000004400 mucous membrane Anatomy 0.000 description 1
• 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
• 231100000219 mutagenic Toxicity 0.000 description 1
• 230000003505 mutagenic effect Effects 0.000 description 1
• 210000005012 myelin Anatomy 0.000 description 1
• 108700003805 myo-inositol-1 (or 4)-monophosphatase Proteins 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• 238000002663 nebulization Methods 0.000 description 1
• 238000013188 needle biopsy Methods 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 108090000126 neurexophilin Proteins 0.000 description 1
• 102000003819 neurexophilin Human genes 0.000 description 1
• 230000008906 neuronal response Effects 0.000 description 1
• 230000006576 neuronal survival Effects 0.000 description 1
• 230000003448 neutrophilic effect Effects 0.000 description 1
• VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
• 102000046701 nicastrin Human genes 0.000 description 1
• 108700022821 nicastrin Proteins 0.000 description 1
• 231100001160 nonlethal Toxicity 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 229940053934 norethindrone Drugs 0.000 description 1
• VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
• 210000004492 nuclear pore Anatomy 0.000 description 1
• 238000003499 nucleic acid array Methods 0.000 description 1
• 238000003171 nucleic acid assay format Methods 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 201000002674 obstructive nephropathy Diseases 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 229940127234 oral contraceptive Drugs 0.000 description 1
• 239000003539 oral contraceptive agent Substances 0.000 description 1
• 229940053180 other antiepileptics in atc Drugs 0.000 description 1
• 230000001151 other effect Effects 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000004792 oxidative damage Effects 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 230000010627 oxidative phosphorylation Effects 0.000 description 1
• 101150113889 pacs-1 gene Proteins 0.000 description 1
• 108010008746 palmitoyl CoA oxidase Proteins 0.000 description 1
• MNBKLUUYKPBKDU-BBECNAHFSA-N palmitoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MNBKLUUYKPBKDU-BBECNAHFSA-N 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 239000000123 paper Substances 0.000 description 1
• AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
• 239000000199 parathyroid hormone Substances 0.000 description 1
• 229960001319 parathyroid hormone Drugs 0.000 description 1
• 230000008289 pathophysiological mechanism Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 108010007262 peptidylglycine monooxygenase Proteins 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 210000004976 peripheral blood cell Anatomy 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 230000002974 pharmacogenomic effect Effects 0.000 description 1
• 238000001050 pharmacotherapy Methods 0.000 description 1
• 229950000688 phenothiazine Drugs 0.000 description 1
• 150000002990 phenothiazines Chemical class 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
• 150000003905 phosphatidylinositols Chemical class 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 108010012455 phospholipid serine base exchange enzyme Proteins 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 238000006303 photolysis reaction Methods 0.000 description 1
• 230000015843 photosynthesis, light reaction Effects 0.000 description 1
• SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 230000003169 placental effect Effects 0.000 description 1
• 239000013600 plasmid vector Substances 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 210000004910 pleural fluid Anatomy 0.000 description 1
• 231100000614 poison Toxicity 0.000 description 1
• 239000002574 poison Substances 0.000 description 1
• 231100000572 poisoning Toxicity 0.000 description 1
• 230000000607 poisoning effect Effects 0.000 description 1
• 229920002857 polybutadiene Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 150000004804 polysaccharides Polymers 0.000 description 1
• 239000004800 polyvinyl chloride Substances 0.000 description 1
• 229920000915 polyvinyl chloride Polymers 0.000 description 1
• 231100000683 possible toxicity Toxicity 0.000 description 1
• SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
• 230000003334 potential effect Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 238000002203 pretreatment Methods 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 230000001072 progestational effect Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 108010042589 prolyl T RNA synthetase Proteins 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 210000004129 prosencephalon Anatomy 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 201000001514 prostate carcinoma Diseases 0.000 description 1
• 108010043671 prostatic acid phosphatase Proteins 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 125000006239 protecting group Chemical group 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 229960000856 protein c Drugs 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 230000007398 protein translocation Effects 0.000 description 1
• 201000001474 proteinuria Diseases 0.000 description 1
• 229940001470 psychoactive drug Drugs 0.000 description 1
• 239000004089 psychotropic agent Substances 0.000 description 1
• 230000005180 public health Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• XKMLYUALXHKNFT-UHFFFAOYSA-N rGTP Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O XKMLYUALXHKNFT-UHFFFAOYSA-N 0.000 description 1
• 108010062302 rac1 GTP Binding Protein Proteins 0.000 description 1
• 239000002534 radiation-sensitizing agent Substances 0.000 description 1
• 108010036805 rap1 GTP-Binding Proteins Proteins 0.000 description 1
• 108010014186 ras Proteins Proteins 0.000 description 1
• 239000003642 reactive oxygen metabolite Substances 0.000 description 1
• 230000009719 regenerative response Effects 0.000 description 1
• 238000000611 regression analysis Methods 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 239000003488 releasing hormone Substances 0.000 description 1
• 230000008327 renal blood flow Effects 0.000 description 1
• 201000010174 renal carcinoma Diseases 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 229950009147 repirinast Drugs 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 108091000053 retinol binding Proteins 0.000 description 1
• 102000029752 retinol binding Human genes 0.000 description 1
• 108010092211 ribosomal protein S33 Proteins 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 208000026451 salivation Diseases 0.000 description 1
• 201000000980 schizophrenia Diseases 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 101150047761 sdhA gene Proteins 0.000 description 1
• 101150015999 sec24 gene Proteins 0.000 description 1
• 239000000932 sedative agent Substances 0.000 description 1
• 230000001624 sedative effect Effects 0.000 description 1
• 210000001625 seminal vesicle Anatomy 0.000 description 1
• 230000036303 septic shock Effects 0.000 description 1
• 208000026775 severe diarrhea Diseases 0.000 description 1
• 231100000847 severe hepatotoxicity Toxicity 0.000 description 1
• 108010006908 signal sequence receptor Proteins 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 229910000077 silane Inorganic materials 0.000 description 1
• 231100000188 sister chromatid exchange Toxicity 0.000 description 1
• 231100000046 skin rash Toxicity 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 101150082727 sod-3 gene Proteins 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 239000006283 soil fumigant Substances 0.000 description 1
• 108040000979 soluble NSF attachment protein activity proteins Proteins 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 101150036683 sre1 gene Proteins 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000003637 steroidlike Effects 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 238000012706 support-vector machine Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 230000007470 synaptic degeneration Effects 0.000 description 1
• 230000003390 teratogenic effect Effects 0.000 description 1
• 201000008321 testicular Leydig cell tumor Diseases 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• 239000004753 textile Substances 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 229960000984 tocofersolan Drugs 0.000 description 1
• 231100000721 toxic potential Toxicity 0.000 description 1
• 239000003440 toxic substance Substances 0.000 description 1
• 231100000820 toxicity test Toxicity 0.000 description 1
• 231100000622 toxicogenomics Toxicity 0.000 description 1
• 230000002110 toxicologic effect Effects 0.000 description 1
• 231100000583 toxicological profile Toxicity 0.000 description 1
• 238000013417 toxicology model Methods 0.000 description 1
• 238000002627 tracheal intubation Methods 0.000 description 1
• FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
• 239000000814 tuberculostatic agent Substances 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 108010084736 ubiquitin carrier proteins Proteins 0.000 description 1
• 108020003234 urea transporter Proteins 0.000 description 1
• 102000006030 urea transporter Human genes 0.000 description 1
• 229940116269 uric acid Drugs 0.000 description 1
• 210000003934 vacuole Anatomy 0.000 description 1
• 208000019553 vascular disease Diseases 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 201000010653 vesiculitis Diseases 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 208000029257 vision disease Diseases 0.000 description 1
• 230000004393 visual impairment Effects 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 235000019168 vitamin K Nutrition 0.000 description 1
• 239000011712 vitamin K Substances 0.000 description 1
• 150000003721 vitamin K derivatives Chemical class 0.000 description 1
• 235000019143 vitamin K2 Nutrition 0.000 description 1
• 239000011728 vitamin K2 Substances 0.000 description 1
• 229940046010 vitamin k Drugs 0.000 description 1
• 102100039135 von Willebrand factor A domain-containing protein 8 Human genes 0.000 description 1
• 238000004073 vulcanization Methods 0.000 description 1
• 235000012431 wafers Nutrition 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 239000002676 xenobiotic agent Substances 0.000 description 1
• 230000002034 xenobiotic effect Effects 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229940107931 zovirax Drugs 0.000 description 1
• 239000002076 α-tocopherol Substances 0.000 description 1
• 235000004835 α-tocopherol Nutrition 0.000 description 1